Publications

1. Corey Z, Lehman E, Lemack GE, Clifton MM, Klausner AP, Mehta A, Atiemo H, Lee R, Sorensen M, Smith R, Buckley J, Thompson RH, Breyer BN, Badalato GM, Wallen EM, Cain M, Wolf JS Jr, Raman JD. Practice Readiness? Trends in Chief Resident Case Logs vs Subsequent Case Log Data in Clinical Practice. Urol Pract. 2024 Nov; 11 (6):1007-1013 Epub 2024 July 18
   View PubMed
2. Khanna A, Gottlich HC, Dorr M, Lohse CM, Zganjar A, Sharma V, Joyce D, Potretzke A, Britton C, Rule AD, Boorjian SA, Leibovich BC, Thompson RH. Reply by Authors. J Urol 2024 Oct; 212 (4):559 Epub 2024 July 30
   View PubMed
3. Britton CJ, Sharma V, Lohse CM, Potretzke AM, Boorjian SA, Thompson RH, Cheville JC, Leibovich BC. Incidence and predictors of ipsilateral local recurrence following partial nephrectomy. Urol Oncol. 2024 Oct; 42 (10):334.e1-334.e9 Epub 2024 June 29
   View PubMed
4. Khanna A, Gottlich HC, Dorr M, Lohse CM, Zganjar A, Sharma V, Joyce D, Potretzke A, Britton C, Rule AD, Boorjian SA, Leibovich BC, Thompson RH. End-Stage Kidney Disease After Partial and Radical Nephrectomy Among Patients With Severe Chronic Kidney Disease. J Urol. 2024 Oct; 212 (4):550-559 Epub 2024 June 27
   View PubMed
5. Tekin B, Cubilla AL, Cheville JC, Smith CY, Jenkins SM, Dasari S, Enninga EAL, Norgan AP, Menon S, Whaley RD, Hernandez LH, Jimenez RE, Garcia JJ, Thompson RH, Leibovich BC, Karnes RJ, Boorjian SA, Pagliaro LC, Erickson LA, Guo R, Gupta S. High-risk human papilloma virus status & outcomes for penile squamous cell carcinoma: A single institution experience. Hum Pathol. 2024 Aug; 150:9-19 Epub 2024 June 21
   View PubMed
6. Zganjar A, Khanna A, Joyce D, Nichols P, Britton C, Lohse CM, Cheville JC, Gupta S, Potretzke AM, Thompson RH, Leibovich BC, Boorjian SA, Sharma V. Mayo Clinic Validation of the AUA Risk Groups for Localized Renal Cell Carcinoma. J Urol. 2024 Aug; 212 (2):331-341 Epub 2024 May 30
   View PubMed
7. Zganjar A, Khanna A, Joyce D, Nichols P, Britton C, Lohse CM, Cheville JC, Gupta S, Potretzke AM, Thompson RH, Leibovich BC, Boorjian SA, Sharma V. Reply by Authors. J Urol 2024 Aug; 212 (2):341 Epub 2024 May 30
   View PubMed
8. Sabov M, Denic A, Mullan AF, Luehrs AC, Kline TL, Erickson BJ, Potretzke TA, Thompson RH, Sharma V, Harris PC, Rule AD. Association of Kidney Cysts With Progressive CKD After Radical Nephrectomy. Am J Kidney Dis. 2024 Jul; 84 (1):62-72.e1 Epub 2024 Jan 26
   View PubMed
9. Tekin B, Sali AP, Menon S, Cheville JC, Smith CY, Jenkins SM, Dasari S, Enninga EAL, Norgan AP, Cubilla AL, Whaley RD, Hernandez LH, Jimenez RE, Garcia JJ, Thompson RH, Leibovich BC, Karnes RJ, Boorjian SA, Pagliaro LC, Erickson LA, Guo R, Gupta S. Comparison of a modified staging system with 8th edition AJCC criteria in a North American cohort of pT2/pT3 HPV-negative penile squamous cell carcinoma. Hum Pathol. 2024 Jun; 148:81-86 Epub 2024 May 22
   View PubMed
10. Purdue MP, Dutta D, Machiela MJ, Gorman BR, Winter T, Okuhara D, Cleland S, Ferreiro-Iglesias A, Scheet P, Liu A, Wu C, Antwi SO, Larkin J, Zequi SC, Sun M, Hikino K, Hajiran A, Lawson KA, Carcano F, Blanchet O, Shuch B, Nepple KG, Margue G, Sundi D, Diver WR, Folgueira MAAK, van Bokhoven A, Neffa F, Brown KM, Hofmann JN, Rhee J, Yeager M, Cole NR, Hicks BD, Manning MR, Hutchinson AA, Rothman N, Huang WY, Linehan WM, Lori A, Ferragu M, Zidane-Marinnes M, Serrano SV, Magnabosco WJ, Vilas A, Decia R, Carusso F, Graham LS, Anderson K, Bilen MA, Arciero C, Pellegrin I, Ricard S, Scelo G, Banks RE, Vasudev NS, Soomro N, Stewart GD, Adeyoju A, Bromage S, Hrouda D, Gibbons N, Patel P, Sullivan M, Protheroe A, Nugent FI, Fournier MJ, Zhang X, Martin LJ, Komisarenko M, Eisen T, Cunningham SA, Connolly DC, Uzzo RG, Zaridze D, Mukeria A, Holcatova I, Hornakova A, Foretova L, Janout V, Mates D, Jinga V, Rascu S, Mijuskovic M, Savic S, Milosavljevic S, Gaborieau V, Abedi-Ardekani B, McKay J, Johansson M, Phouthavongsy L, Hayman L, Li J, Lungu I, Bezerra SM, Souza AG, Sares CTG, Reis RB, Gallucci FP, Cordeiro MD, Pomerantz M, Lee GM, Freedman ML, Jeong A, Greenberg SE, Sanchez A, Thompson RH, Sharma V, Thiel DD, Ball CT, Abreu D, Lam ET, Nahas WC, Master VA, Patel AV, Bernhard JC, Freedman ND, Bigot P, Reis RM, Colli LM, Finelli A, Manley BJ, Terao C, Choueiri TK, Carraro DM, Houlston R, Eckel-Passow JE, Abbosh PH, Ganna A, Brennan P, Gu J, Chanock SJ, BioBank Japan Project//FinnGen. Multi-ancestry genome-wide association study of kidney cancer identifies 63 susceptibility regions. Nat Genet. 2024 May; 56 (5):809-818 Epub 2024 Apr 26
    View PubMed
11. Campbell RA, Khanna A, Boorjian SA, Knorr J, Cox R, Nicholas M, Cheville J, Sharma V, Murthy PB, Tarrell R, Thapa P, Tollefson MK, Thompson RH, Frank I, Karnes RJ, Haber GP, Lee B. Impact of Neoadjuvant Chemotherapy on Pathologic Downstaging in Patients With Variant Histology Undergoing Radical Cystectomy. Clin Genitourin Cancer. 2024 Apr; 22 (2):157-163.e1 Epub 2023 Oct 26
    View PubMed
12. Gupta S, Dasari S, Sharma V, Atwell TD, Sivasankaran G, Smoley SA, Hardcastle JJ, Lohse CM, Tekin B, Jimenez RE, Thompson RH, Boorjian SA, Leibovich BC, Cheville JC. Metastatic clear cell papillary renal cell 'tumour'. Histopathology 2024 Apr; 84 (5):905-909 Epub 2023 Dec 26
    View PubMed
13. Nielson KJ, Rowsey R, Dasari S, Sukov WR, Kipp BR, Raghunathan A, Whaley RD, Ebare K, Stanton ML, Reynolds JP, Sharma V, Thompson RH, Boorjian SA, Leibovich BC, Hernandez LH, Jimenez RE, Cheville JC, Gupta S. Single nucleotide polymorphism (SNP) chromosomal microarray as a diagnostic tool for mucinous tubular and spindle cell carcinoma: A validation study. Hum Pathol. 2024 Apr; 146:57-65 Epub 2024 Apr 12
    View PubMed
14. Khanna A, Antolin A, Bar O, Ben-Ayoun D, Zohar M, Boorjian SA, Frank I, Shah P, Sharma V, Thompson RH, Wolf T, Asselmann D, Tollefson M. Automated Identification of Key Steps in Robotic-Assisted Radical Prostatectomy Using Artificial Intelligence. J Urol. 2024 Apr; 211 (4):575-584 Epub 2024 Jan 24
    View PubMed
15. Dasari S, McCarthy MR, Wojcik AA, Pitel BA, Samaddar A, Tekin B, Whaley RD, Raghunathan A, Hernandez LH, Jimenez RE, Stish BJ, Thompson RH, Leibovich BC, Boorjian SA, Jeffrey Karnes R, Childs DS, Quevedo JF, Kwon ED, Pagliaro LC, Costello BA, Halling KC, Cheville JC, Kipp BR, Gupta S. Genomic attributes of prostate cancer across primary and metastatic noncastrate and castrate resistant disease states: a next generation sequencing study of 183 patients. Prostate Cancer Prostatic Dis. 2024 Feb 27. [Epub ahead of print]
    View PubMed
16. Mian AH, Tollefson MK, Shah P, Sharma V, Mian A, Thompson RH, Boorjian SA, Frank I, Khanna A. Navigating Now and Next: Recent Advances and Future Horizons in Robotic Radical Prostatectomy. J Clin Med. 2024 Jan 9; 13 (2) Epub 2024 Jan 09
    View PubMed
17. Tekin B, Cheville JC, Herrera Hernandez L, Negron V, Smith CY, Jenkins SM, Dasari S, Enninga EAL, Norgan AP, Menon S, Cubilla AL, Whaley RD, Jimenez RE, Thompson RH, Leibovich BC, Karnes RJ, Boorjian SA, Pagliaro LC, Erickson LA, Guo R, Gupta S. Assessment of PD-L1, TROP2, and nectin-4 expression in penile squamous cell carcinoma. Hum Pathol. 2023 Dec; 142:42-50 Epub 2023 Nov 15
    View PubMed
18. Gilani SI, Dasari S, Tekin B, Hernandez LH, Cheville JC, Jimenez RE, Rech KL, Dao LN, Howard MT, Dalland JC, Chiu A, Theis JD, Vrana JA, Grogan M, Thompson RH, Leibovich BC, Karnes RJ, Boorjian SA, Dispenzieri A, McPhail ED, Gupta S. Identification of amyloidosis of the urinary tract and prostate: Opportunities for early diagnosis & intervention in systemic disease. Hum Pathol. 2023 Dec; 142:62-67 Epub 2023 Nov 17
    View PubMed
19. Yip W, Ghoreifi A, Gerald T, Lee R, Howard J, Asghar A, Khanna A, Cai J, Aron M, Gill I, Thompson RH, Uzzo R, Margulis V, Singla N, Djaladat H. Perioperative Complications and Oncologic Outcomes of Nephrectomy Following Immune Checkpoint Inhibitor Therapy: A Multicenter Collaborative Study. Eur Urol Oncol 2023 Dec; 6 (6):604-610 Epub 2023 Mar 31
    View PubMed
20. Pessoa RR, Nabavizadeh R, Quevedo F, Joyce DD, Lohse CM, Sharma V, Costello BA, Boorjian SA, Thompson RH, Leibovich BC, Cheville JC. The Impact of Metastasis Histopathology on Oncologic Outcomes for Patients With Surgically Resected Metastatic Renal Cell Carcinoma. J Urol. 2023 Oct; 210 (4):611-618 Epub 2023 June 20
    View PubMed
21. Denic A, Gaddam M, Moustafa A, Mullan AF, Luehrs AC, Sharma V, Thompson RH, Smith ML, Alexander MP, Lerman LO, Barisoni L, Rule AD. Tubular and Glomerular Size by Cortex Depth as Predictor of Progressive CKD after Radical Nephrectomy for Tumor. J Am Soc Nephrol. 2023 Sep 1; 34 (9):1535-1545 Epub 2023 July 11
    View PubMed
22. Roshandel MR, Lohse CM, Sharma V, Thompson RH, Boorjian SA, Leibovich BC. Implications of Tumor Surgery in Horseshoe Kidneys: A Comparative Study of Outcomes and Surgical Practices. Urology. 2023 Sep; 179:87-94 Epub 2023 June 17
    View PubMed
23. Margolin EJ, Schoenfeld D, Miles CH, Merrill SB, Raman JD, Thompson RH, Reese AC, Parekh DJ, Brown ET, Klausner A, Williams DH, Lee RK, Zaslau S, Guzzo TJ, Shenot PJ, Anderson CB, Badalato GM. Longitudinal Changes in the Operative Experience for Junior Urology Residents. Urology. 2023 Sep; 179:32-38 Epub 2023 July 01
    View PubMed
24. Rodrigues Pessoa R, Zhang H, Zganjar A, Nabavizadeh R, Packiam VT, Lohse CM, Cheville JC, Pagliaro LC, Costello BA, Boorjian SA, Thompson RH, Lucien F, Dong H, Leibovich BC. Circulating antigen-primed cytotoxic T-cells in patients with renal tumors treated with surgery. Urol Oncol. 2023 Sep; 41 (9):393.e1-393.e7 Epub 2023 July 04
    View PubMed
25. Asghar MS, Denic A, Mullan AF, Moustafa A, Barisoni L, Alexander MP, Stegall MD, Augustine J, Leibovich BC, Thompson RH, Rule AD. Age-Based Versus Young-Adult Thresholds for Nephrosclerosis on Kidney Biopsy and Prognostic Implications for CKD. J Am Soc Nephrol. 2023 Aug 1; 34 (8):1421-1432 Epub 2023 May 31
    View PubMed
26. Denic A, Mullan AF, Alexander MP, Wilson LD, Augustine J, Luehrs AC, Stegall MD, Kline TL, Sharma V, Thompson RH, Rule AD. An Improved Method for Estimating Nephron Number and the Association of Resulting Nephron Number Estimates with Chronic Kidney Disease Outcomes. J Am Soc Nephrol. 2023 Jul 1; 34 (7):1264-1278 Epub 2023 Mar 23
    View PubMed
27. McCarthy MR, Nichols PE, Sharma V, Stanton ML, Reynolds JP, Pitel BA, Halling KC, Lohse CM, Herrera-Hernandez L, Thompson RH, Leibovich BC, Jimenez RE, Boorjian SA, Cheville JC, Gupta S. Molecular and Immunophenotypic Correlates of Metastatic Epithelioid Angiomyolipoma Include Alterations of TP53, RB1, and ATRX. Arch Pathol Lab Med. 2023 Jul 01; 147(7):817-825.
    View PubMed
28. An Z, Hsu MA, Gicobi JK, Xu T, Harrington SM, Zhang H, Pavelko KD, Hirdler JB, Lohse CM, Nabavizadeh R, Pessoa RR, Sharma V, Thompson RH, Leibovich BC, Dong H, Lucien F. A Novel PD-L1 Antibody Promotes Antitumor Function of Peripheral Cytotoxic Lymphocytes after Radical Nephrectomy in Patients with Renal Cell Carcinoma. J Immunol. 2023 Jun 15; 210 (12):2029-2037
    View PubMed
29. Tekin B, Dasari S, Theis JD, Vrana JA, Murray DL, Oglesbee D, Thompson RH, Leibovich BC, Boorjian SA, Whaley RD, Hernandez LH, Jimenez RE, Cheville JC, Karnes RJ, Sukov WR, Gupta S. Mass spectrometry-based assessment of prostate cancer-associated crystalloids reveals enrichment for growth and differentiation factor 15. Hum Pathol. 2023 May; 135:35-44 Epub 2023 Mar 09
    View PubMed
30. Britton CJ, Sharma V, Lohse CM, Thompson RH, Lieske JC, Rule AD, Potretzke AM. Non-race-based Glomerular Filtration Rates to Estimate Renal Functional Outcomes Following Radical and Partial Nephrectomy. Urol Pract 2023 May; 10 (3):213-216 Epub 2023 Jan 24
    View PubMed
31. Britton CJ, Sharma V, Lohse CM, Thompson RH, Lieske JC, Rule AD, Potretzke AM. Reply by Authors. Urol Pract. 2023 May; 10 (3):216 Epub 2023 Mar 09
    View PubMed
32. Myers A, Frank I, Shah PH, Tarrell RF, Baird B, Dora C, Karnes RJ, Thompson RH, Tollefson MK, Boorjian SA, Lyon TD. Intraoperative Blood Transfusion Is Associated With Increased Risk of Venous Thromboembolism After Radical Cystectomy. J Urol. 2023 Mar; 209 (3):525-531 Epub 2022 Nov 29
    View PubMed
33. Britton CJ, Andrews JR, Wallis CJD, Sharma V, Leibovich BC, Thompson RH, Boorjian SA, Bhindi B, Costello BA. Deferred cytoreductive nephrectomy in the management of metastatic renal cell carcinoma: A systematic review and meta-analysis. Urol Oncol. 2023 Mar; 41 (3):125-136 Epub 2022 Oct 28
    View PubMed
34. Avulova S, Benidir T, Cheville JC, Packiam VT, Shah P, Frank I, Tollefson MK, Thompson RH, Karnes RJ, Thapa P, Kulkarni G, Boorjian SA. Prevalence, Predictors, and Oncologic Outcomes of Pelvic Organ Involvement in Women Undergoing Radical Cystectomy. Arch Pathol Lab Med. 2023 Feb 1; 147 (2):202-207
    View PubMed
35. Lyon TD, Roussel E, Sharma V, Carames G, Lohse CM, Costello BA, Boorjian SA, Thompson RH, Joniau S, Albersen M, Leibovich BC. International Multi-institutional Characterization of the Perioperative Morbidity of Metastasectomy for Renal Cell Carcinoma. Eur Urol Oncol. 2023 Feb; 6 (1):76-83 Epub 2022 Dec 09
    View PubMed
36. Potretzke A, Britton CJ, Sharma V, Lohse CM, Thompson R, Lieske JC, Rule AD. Non-race-based Glomerular Filtration Rates to Estimate Renal Functional Outcomes Following Nephrectomy AUA Journal. 2023.
    
37. Joyce DD, Soligo M, Morlacco A, Latuche LJR, Schulte PJ, Boorjian SA, Frank I, Gettman MT, Thompson RH, Tollefson MK, Karnes RJ. Effect of Preoperative Multiparametric Magnetic Resonance Imaging on Oncologic and Functional Outcomes Following Radical Prostatectomy. Eur Urol Open Sci. 2023 Jan; 47:87-93 Epub 2022 Dec 15
    View PubMed
38. Tekin B, Dasari S, Theis JD, Vrana JA, Murray DL, Oglesbee D, Thompson RH, Leibovich BC, Boorjian SA, Whaley RD, Herrera Hernandez L, Jimenez RE, Cheville JC, Karnes RJ, Sukov WR, Gupta S. Mass spectrometry–based assessment of prostate cancer–associated crystalloids reveals enrichment for growth and differentiation factor 15. Human Pathology. 2023; 135:35-44
    
39. Sharma V, Wymer KM, Joyce DD, Moriarty J, Khanna A, Borah BJ, Thompson RH, Costello BA, Leibovich BC, Boorjian SA. Cost-effectiveness of Adjuvant Pembrolizumab After Nephrectomy for High-risk Renal Cell Carcinoma: Insights for Patient Selection From a Markov Model. J Urol. 2023 Jan; 209 (1):89-98 Epub 2022 Sept 06
    View PubMed
40. Gupta S, Sukov WR, Vanderbilt CM, Shen W, Herrera-Hernandez L, Lohse CM, Thompson RH, Boorjian SA, Leibovich BC, Jimenez RE, Cheville JC. A contemporary guide to chromosomal copy number profiling in the diagnosis of renal cell carcinoma. Urol Oncol. 2022 Dec; 40 (12):512-524 Epub 2021 June 04
    View PubMed
41. Britton CJ, Sharma V, Lohse CM, Lieske JC, Nichols PE, Khanna A, Cheville JC, Boorjian SA, Leibovich BC, Thompson RH, Potretzke AM. Progression of Chronic Kidney Disease Following Radical and Partial Nephrectomy. Urology. 2022 Nov; 169:125-133 Epub 2022 July 22
    View PubMed
42. Tsivian M, Joyce DD, Packiam VT, Lohse CM, Boorjian SA, Potretzke TA, Chow GK, Leibovich BC, Sharma V, Thompson RH. Unplanned Conversion From Partial to Radical Nephrectomy: An Analysis of Incidence, Etiology, and Risk Factors. J Urol. 2022 Nov; 208 (5):960-968 Epub 2022 June 24
    View PubMed
43. Gupta S, Nichols P, Lohse CM, Kosari F, Kattah AG, Harris FR, Karagouga G, Mehra R, Fine SW, Reuter VE, Herrera-Hernandez L, Zganjar AJ, Britton CJ, Potretzke AM, Boorjian SA, Thompson RH, Jimenez RE, Leibovich BC, Garovic VD, Cheville JC, Sharma V. Renin Production by Juxtaglomerular Cell Tumors and Clear Cell Renal Cell Carcinoma and the Role of Angiotensin Signaling Inhibitors. Mayo Clin Proc. 2022 Nov; 97 (11):2050-2064 Epub 2022 June 24
    View PubMed
44. Parikh NN, Thompson RH. Editorial Commentary. Urol Pract. 2022 Nov; 9 (6):603 Epub 2022 Sept 05
    View PubMed
45. Britton CJ, Andrews JR, Wallis , C, Sharma V, Leibovich BC, Thompson R, Boorjian SA, Bhindi , B, Costello BA. Deferred cytoreductive nephrectomy in the management of metastatic renal cell carcinoma: A systematic review and meta-analysis Urologic Oncology. 2022; 41(3):125-36.
    
46. Zafar R, Schrader LJ, Cheville JC, Schoolmeester JK, Roden AC, Aubry MC, Yi ES, Raghunathan A, Herrera-Hernandez L, Thompson RH, Boorjian SA, Leibovich BC, Keeney GL, Jimenez RE, Gupta S. A diagnostic approach to paratesticular lesions with tubulopapillary architecture: a series of 16 serous borderline tumors/low-grade serous carcinoma and 14 well-differentiated papillary mesothelial tumors and mesothelioma. Hum Pathol. 2022 Oct; 128:31-47. Epub 2022 Jul 06.
    View PubMed
47. Rathi N, Yasuda Y, Palacios DA, Attawettayanon W, Li J, Bhindi B, Thompson RH, Liss MA, Derweesh IH, Weight CJ, Eltemamy M, Abouassaly R, Campbell SC. Split Renal Function Is Fundamentally Important for Predicting Functional Recovery After Radical Nephrectomy. Eur Urol Open Sci. 2022 Jun; 40:112-116 Epub 2022 May 05
    View PubMed
48. Gupta S, Farooq A, Rowsey RA, Rahman MA, Shen W, Herrera-Hernandez L, Raghunathan A, Thompson RH, Boorjian SA, Leibovich BC, Cheville JC, Jimenez RE. Cytogenetics of spermatocytic tumors with a discussion of gain of chromosome 12p in anaplastic variants. Hum Pathol. 2022 Jun; 124:85-95 Epub 2022 Apr 01
    View PubMed
49. Takeuchi M, Froemming AT, Kawashima A, Thapa P, Carter RE, Cheville JC, Thompson RH, Takahashi N. Magnetic resonance imaging (MRI) helps differentiate renal cell carcinoma with sarcomatoid differentiation from renal cell carcinoma without sarcomatoid differentiation. Abdom Radiol (NY). 2022 Jun; 47 (6):2168-2177 Epub 2022 Apr 05
    View PubMed
50. Olson EM, Dines VA, Ryan SM, Halvorsen AJ, Long TR, Price DL, Thompson RH, Tollefson MM, Van Gompel JJ, Oxentenko AS. Multispecialty quality improvement study to address professional misidentification and bias. Mayo Clinic Proceedings. 2022 Apr; 97 (4):658-67
    
51. Olson EM, Dines VA, Ryan SM, Halvorsen AJ, Long TR, Price DL, Thompson RH, Tollefson MM, Van Gompel JJ, Oxentenko AS. Physician Identification Badges: A Multispecialty Quality Improvement Study to Address Professional Misidentification and Bias. Mayo Clin Proc. 2022 Apr; 97 (4):658-667
    View PubMed
52. Khanna A, Miest T, Sharma V, Campbell R, Hensley P, Thapa P, Zganjar A, Tollefson MK, Thompson RH, Frank I, Karnes RJ, Murthy PB, Haber GP, Navai N, Kamat AM, Dinney C, Lee B, Boorjian SA. Role of Lymphadenectomy during Radical Cystectomy for Nonmuscle-Invasive Bladder Cancer: Results from a Multi-Institutional Experience. J Urol. 2022 Mar; 207(3):551-558. Epub 2021 Oct 25.
    View PubMed
53. Findlay BL, Thompson RH. Editorial Commentary. Urol Pract 2022 Mar; 9 (2):187 Epub 2021 Mar 01
    View PubMed
54. Miest T, Khanna A, Sharma V, Hensley PJ, Campbell R, Thapa P, Zganjar A, Tollefson MK, Thompson RH, Frank I, Karnes RJ, Potretzke A, Matin SF, Murthy PB, Haber GP, Lee B, Boorjian SA. Development and Validation of a Risk-Adapted Scoring Model for Metachronous Upper Tract Urothelial Carcinoma following Radical Cystectomy. J Urol. 2022 Feb; 207(2):284-292. Epub 2021 Sep 22.
    View PubMed
55. Gupta S, Erickson LA, Lohse CM, Shen W, Pitel BA, Knight SM, Halling KC, Herrera-Hernandez L, Boorjian SA, Thompson RH, Leibovich BC, Jimenez RE, Cheville JC. Assessment of Risk of Hereditary Predisposition in Patients With Melanoma and/or Mesothelioma and Renal Neoplasia. JAMA Netw Open. 2021 Nov 1; 4 (11):e2132615 Epub 2021 Nov 01
    View PubMed
56. Klett DE, Tsivian M, Packiam VT, Lohse CM, Ahmed ME, Potretzke TA, Gopalakrishna A, Boorjian SA, Thompson RH, Leibovich BC, Potretzke AM. Partial versus radical nephrectomy in clinical T2 renal masses. Int J Urol. 2021 Nov; 28 (11):1149-1154 Epub 2021 Aug 11
    View PubMed
57. Ricaurte Archila L, Denic A, Mullan AF, Narasimhan R, Bogojevic M, Thompson RH, Leibovich BC, Sangaralingham SJ, Smith ML, Alexander MP, Rule AD. A Higher Foci Density of Interstitial Fibrosis and Tubular Atrophy Predicts Progressive CKD after a Radical Nephrectomy for Tumor. J Am Soc Nephrol. 2021 Oct; 32 (10):2623-2633 Epub 2021 June 18
    View PubMed
58. Khanna A, Zganjar A, Lyon T, Shah P, Tollefson MK, Karnes RJ, Tarrell R, Thapa P, Thompson RH, Frank I, Boorjian SA. A Contemporary Analysis of Urethral Recurrence following Radical Cystectomy. J Urol. 2021 Oct; 206 (4):970-977 Epub 2021 May 25
    View PubMed
59. Sharma V, Miest TS, Juvet TS, Toussi A, Packiam V, Chamie K, Matin SF, Boorjian SA, Thompson RH, Frank I, Tollefson MK, Potretzke AM. The Impact of Upper Tract Urothelial Carcinoma Diagnostic Modality on Intravesical Recurrence after Radical Nephroureterectomy: A Single Institution Series and Updated Meta-Analysis. J Urol. 2021 Sep; 206 (3):558-567 Epub 2021 Apr 28
    View PubMed
60. Miest TS, Sharma V, Karnes RJ, Boorjian SA, Thompson RH, Frank I, Tollefson MK. Incidence and predictors of occult preoperative deep vein thrombosis at radical cystectomy for urothelial carcinoma. Can Urol Assoc J. 2021 Sep; 15 (9):E471-E475
    View PubMed
61. Gao RW, Tollefson MK, Thompson RH, Potretzke AM, Quevedo FJ, Choo R, Davis BJ, Pisansky TM, Harmsen WS, Stish BJ. Predictors of Locoregional Recurrence and Delineation of Adjuvant Radiation Therapy Fields for Patients With Upper Tract Urothelial Carcinoma Receiving Nephroureterectomy. Pract Radiat Oncol. 2021 Sep-Oct; 11 (5):e468-e476 Epub 2021 Feb 23
    View PubMed
62. Miest TS, Sharma V, Boeri L, Tollefson MK, Thompson RH, Boorjian SA, Frank I, Karnes RJ. Does Ureteral Stent Drainage Prior to Cystectomy Increase the Risk of Subsequent Upper Tract Urothelial Carcinoma and Ureteral Complications? Urology. 2021 Jul; 153:215-220 Epub 2020 Aug 05
    View PubMed
63. Ahmed ME, Joshi VB, Alamiri J, Viers BR, Granberg CF, Thompson RH. A Survey of Urology Residency Program Directors Assessing Criteria to Interview Applicants during the COVID-19 Pandemic. Urol Pract. 2021 Jul; 8 (4):472-479 Epub 2021 May 10
    View PubMed
64. Freitag CE, Sukov WR, Bryce AH, Berg JV, Vanderbilt CM, Shen W, Smadbeck JB, Greipp PT, Ketterling RP, Jenkins RB, Herrera-Hernandez L, Costello BA, Thompson RH, Boorjian SA, Leibovich BC, Jimenez RE, Murphy SJ, Vasmatzis G, Cheville JC, Gupta S. Assessment of isochromosome 12p and 12p abnormalities in germ cell tumors using fluorescence in situ hybridization, single-nucleotide polymorphism arrays, and next-generation sequencing/mate-pair sequencing. Hum Pathol. 2021 Jun; 112:20-34 Epub 2021 Mar 31
    View PubMed
65. Gupta S, Jimenez RE, Herrera-Hernandez L, Lohse CM, Thompson RH, Boorjian SA, Leibovich BC, Cheville JC. Renal Neoplasia in Tuberous Sclerosis: A Study of 41 Patients. Mayo Clin Proc. 2021 Jun; 96 (6):1470-1489 Epub 2021 Jan 29
    View PubMed
66. Lyon TD, Frank I, Tollefson MK, Tarrell RF, Shah PH, Thompson RH, Karnes RJ, Boorjian SA. Association of intraoperative hypothermia with oncologic outcomes following radical cystectomy. Urol Oncol. 2021 Jun; 39 (6):370.e1-370.e8 Epub 2020 Dec 08
    View PubMed
67. Takeuchi M, McDonald JS, Takahashi N, Frank I, Thompson RH, King BF, Kawashima A. Cancer Prevalence and Risk Stratification in Adults Presenting With Hematuria: A Population-Based Cohort Study. Mayo Clin Proc Innov Qual Outcomes. 2021 Apr; 5 (2):308-319 Epub 2021 Jan 21
    View PubMed
68. Findlay BL, Manka MG, Bole R, Dodge NA, Thompson RH, Granberg CF. Defining the Current Landscape of Women in Urology: An Analysis of Female Applicants, Residents, and Faculty at AUA-Accredited Residency Programs. Urology. 2021 Feb; 148:59-63 Epub 2020 Dec 07
    View PubMed
69. Bearrick EN, Packiam V, Bhindi B, Lohse CM, Cheville JC, Mason RJ, Tollefson M, Harrington S, Dong H, Parker AS, Boorjian SA, Thompson RH, Leibovich BC. Creation of a primary tumor tissue expression biomarker-augmented prognostic model for patients with metastatic renal cell carcinoma. Urol Oncol. 2021 Feb; 39 (2):135.e1-135.e8 Epub 2020 Dec 09
    View PubMed
70. Avulova S, Cheville JC, Lohse CM, Gupta S, Potretzke TA, Tsivian M, Thompson RH, Boorjian SA, Leibovich BC, Potretzke AM. Grading Chromophobe Renal Cell Carcinoma: Evidence for a Four-tiered Classification Incorporating Coagulative Tumor Necrosis. Eur Urol. 2021 Feb; 79 (2):225-231 Epub 2020 Nov 07
    View PubMed
71. El Khoury LY, Fu S, Hlady RA, Wagner RT, Wang L, Eckel-Passow JE, Castle EP, Stanton ML, Thompson RH, Parker AS, Ho TH, Robertson KD. Identification of DNA methylation signatures associated with poor outcome in lower-risk Stage, Size, Grade and Necrosis (SSIGN) score clear cell renal cell cancer. Clin Epigenetics. 2021 Jan 18; 13 (1):12
    View PubMed
72. Gupta S, Cheville JC, Galeano BK, Sukov WR, Herrera-Hernandez L, Reed KA, Lohse CM, Thompson RH, Boorjian SA, Leibovich BC, Jimenez RE. Renal neoplasia with papillary architecture involving the pelvicalyceal system. Hum Pathol. 2021 Jan; 107:46-57 Epub 2020 Nov 06
    View PubMed
73. Packiam VT, Tsivian M, Avulova S, Sharma V, Tarrell R, Cheville JC, Frank I, Thompson RH, Tollefson MK, Gettman MT, Karnes RJ, Thapa P, Boorjian SA. Long-term outcomes of incidental prostate cancer at radical cystectomy. Urol Oncol. 2020 Nov; 38 (11):848.e17-848.e22 Epub 2020 July 02
    View PubMed
74. Denic A, Elsherbiny H, Mullan AF, Leibovich BC, Thompson RH, Ricaurte Archila L, Narasimhan R, Kremers WK, Alexander MP, Lieske JC, Lerman LO, Rule AD. Larger Nephron Size and Nephrosclerosis Predict Progressive CKD and Mortality after Radical Nephrectomy for Tumor and Independent of Kidney Function. J Am Soc Nephrol. 2020 Nov; 31 (11):2642-2652 Epub 2020 Sept 16
    View PubMed
75. Joseph JP, Glasgow AE, Carlson RE, Frank I, Tollefson MK, Boorjian SA, Thompson RH, Karnes RJ, Habermann EB, Gettman MT. Screening Postoperative Hemoglobin after Robot-Assisted Radical Prostatectomy-Frequently Used, but Is It Necessary? Urol Pract. 2020 Nov; 7(6):554-558. Epub 2019 Dec 02.
    View PubMed
76. Andrews JR, Sobol I, Frank I, Gettman MT, Thompson RH, Karnes RJ, Boorjian SA, Tollefson MK. Treatment Outcomes in Patients With Symptomatic Lymphoceles Following Radical Prostatectomy Depend Upon Size and Presence of Infection. Urology. 2020 Sep; 143:181-185 Epub 2020 June 17
    View PubMed
77. Gupta S, Vanderbilt CM, Leibovich BC, Herrera-Hernandez L, Raghunathan A, Sukov WR, Voss JS, Barr Fritcher EG, Reed KA, Lohse CM, Reuter VE, Jimenez RE, Thompson RH, Cheville JC. Secondary renal neoplasia following chemotherapy or radiation in pediatric patients. Hum Pathol. 2020 Sep; 103:1-13 Epub 2020 July 15
    View PubMed
78. Sharma V, Wymer KM, Borah BJ, Saigal CS, Litwin MS, Packiam VT, Thompson RH, Tollefson MK, Karnes RJ, Boorjian SA. Cost-Effectiveness of Maintenance bacillus Calmette-Guerin for Intermediate and High Risk Nonmuscle Invasive Bladder Cancer. J Urol. 2020 Sep; 204 (3):442-449 Epub 2020 Mar 19
    View PubMed
79. Marion JT, Schmitz JJ, Schmit GD, Kurup AN, Welch BT, Pasternak JJ, Boorjian SA, Leibovich BC, Atwell TD, Thompson RH. Safety and Efficacy of Retrograde Pyeloperfusion for Ureteral Protection during Renal Tumor Cryoablation. J Vasc Interv Radiol. 2020 Aug; 31 (8):1249-1255 Epub 2020 May 23
    View PubMed
80. Leibovich BC, Lohse CM, Cheville JC, Potretzke TA, Tsivian M, Shah PH, Boorjian SA, Thompson RH, Lyon TD. Renal Cell Carcinoma with Inferior Vena Cava Extension: Can Classification Be Optimized to Predict Perioperative Outcomes? Kidney Cancer. 2020; 4(2):111-115.
    
81. Yang DY, Potretzke TA, Miest TS, Bhindi B, Lohse CM, Cheville JC, King BF, Boorjian SA, Leibovich BC, Thompson RH, Potretzke AM. Timing and distribution of early renal cell carcinoma recurrences stratified by pathological nodal status in M0 patients at the time of nephrectomy. Int J Urol. 2020 Jul; 27 (7):618-622 Epub 2020 May 18
    View PubMed
82. Bacic J, Liu T, Thompson RH, Boorjian SA, Leibovich BC, Golijanin D, Gershman B. Emulating Target Clinical Trials of Radical Nephrectomy With or Without Lymph Node Dissection for Renal Cell Carcinoma. Urology. 2020 Jun; 140:98-106 Epub 2020 Mar 04
    View PubMed
83. Merrill SB, Sohl BS, Thompson RH, Reese AC, Parekh DJ, Lynch JH, Grob BM, Williams DH, Lee RK, Zaslau S, Guzzo TJ, Shenot PJ, Lehman EB, Raman JD. The Balance between Open and Robotic Training among Graduating Urology Residents-Does Surgical Technique Need Monitoring? J Urol. 2020 May; 203 (5):996-1002 Epub 2019 Dec 11
    View PubMed
84. Bhindi B, Asante D, Branda ME, Hickson LJ, Mason RJ, Jeffery MM, Boorjian SA, Leibovich BC, Thompson RH. Survival outcomes for patients with surgically induced end-stage renal disease. Can Urol Assoc J. 2020 Mar; 14 (3):E65-E73 Epub 2019 Sept 27
    View PubMed
85. Lyon TD, Shah ND, Tollefson MK, Shah PH, Sangaralingham LR, Asante D, Thompson RH, Karnes RJ, Frank I, Boorjian SA. AUTHOR REPLY. Urology 2020 Feb; 136:111
    View PubMed
86. Packiam VT, Tyson Ii MD, Tsivian M, Lohse CM, Boorjian SA, Cheville JC, Costello BA, Leibovich BC, Thompson RH. The association of anxiety and depression with perioperative and oncologic outcomes among patients with clear cell renal cell carcinoma undergoing nephrectomy. Urol Oncol. 2020 Feb; 38 (2):41.e19-41.e27 Epub 2019 Nov 21
    View PubMed
87. Lyon TD, Shah ND, Tollefson MK, Shah PH, Sangaralingham LR, Asante D, Thompson RH, Karnes RJ, Frank I, Boorjian SA. Trends in Extended-Duration Venous Thromboembolism Prophylaxis Following Radical Cystectomy. Urology. 2020 Feb; 136:105-111 Epub 2019 Nov 09
    View PubMed
88. Lyon TD, Thompson RH, Shah PH, Lohse CM, Boorjian SA, Costello BA, Cheville JC, Leibovich BC. Complete Surgical Metastasectomy of Renal Cell Carcinoma in the Post-Cytokine Era. J Urol. 2020 Feb; 203 (2):275-282 Epub 2019 Aug 08
    View PubMed
89. Joseph JP, Potretzke TA, Packiam V, Sharma V, Toussi A, Miest TS, Juvet T, Boorjian SA, Thompson RH, Welle CL, Atwell TD, Leibovich BC, Tollefson MK, Potretzke AM. Percutaneous Image-guided Core Needle Biopsy for Upper Tract Urothelial Carcinoma. Urology. 2020 Jan; 135:95-100 Epub 2019 Oct 23
    View PubMed
90. Westerman ME, Boe C, Bole R, Turner NS, Rose SH, Gettman MT, Thompson RH. Evaluation of Medical School Grading Variability in the United States: Are All Honors the Same? Acad Med. 2019 Dec; 94 (12):1939-1945
    View PubMed
91. Golijanin B, Pereira J, Mueller-Leonhard C, Golijanin D, Amin A, Mega A, Boorjian SA, Thompson RH, Leibovich BC, Gershman B. The natural history of renal cell carcinoma with isolated lymph node metastases following surgical resection from 2006 to 2013. Urol Oncol. 2019 Dec; 37 (12):932-940 Epub 2019 Sept 27
    View PubMed
92. Boeri L, Soligo M, Frank I, Boorjian SA, Thompson RH, Tollefson M, Tarrel R, Quevedo FJ, Cheville JC, Karnes RJ. Clinical predictors and survival outcome of patients receiving suboptimal neoadjuvant chemotherapy and radical cystectomy for muscle-invasive bladder cancer: a single-center experience. World J Urol. 2019 Nov; 37 (11):2409-2418 Epub 2019 Feb 25
    View PubMed
93. Tsivian M, Packiam VT, Thompson RH. Tumor Enucleation is Appropriate During Partial Nephrectomy: Against. Eur Urol Focus. 2019 Nov; 5 (6):925-926 Epub 2019 Mar 22
    View PubMed
94. Sharma V, Wymer KM, Borah BJ, Barocas DA, Thompson RH, Karnes RJ, Boorjian SA. Cost-Effectiveness of Active Surveillance, Radical Prostatectomy and External Beam Radiotherapy for Localized Prostate Cancer: An Analysis of the ProtecT Trial. J Urol. 2019 Nov; 202 (5):964-972 Epub 2019 Oct 09
    View PubMed
95. Westerman ME, Cheville JC, Lohse CM, Sharma V, Boorjian SA, Leibovich BC, Thompson RH. Long-Term Outcomes of Patients With Low Grade Cystic Renal Epithelial Neoplasms. Urology. 2019 Nov; 133:145-150 Epub 2019 July 26
    View PubMed
96. Murray CA, Welch BT, Schmit GD, Schmitz JJ, Weisbrod AJ, Callstrom MR, Welch TL, Thompson RH, Kurup AN, Boorjian SA, Atwell TD. Safety and Efficacy of Percutaneous Image-guided Cryoablation of Completely Endophytic Renal Masses. Urology. 2019 Nov; 133:151-156 Epub 2019 Aug 12
    View PubMed
97. Welch BT, Shah PH, Thompson RH, Atwell TD. The current status of thermal ablation in the management of T1b renal masses. Int J Hyperthermia. 2019 Oct; 36 (2):31-36
    View PubMed
98. Gupta S, Cheville JC, Jungbluth AA, Zhang Y, Zhang L, Chen YB, Tickoo SK, Fine SW, Gopalan A, Al-Ahmadie HA, Sirintrapun SJ, Blum KA, Lohse CM, Hakimi AA, Thompson RH, Leibovich BC, Berger MF, Arcila ME, Ross DS, Ladanyi M, Antonescu CR, Reuter VE. JAK2/PD-L1/PD-L2 (9p24.1) amplifications in renal cell carcinomas with sarcomatoid transformation: implications for clinical management. Mod Pathol. 2019 Sep; 32 (9):1344-1358 Epub 2019 Apr 17
    View PubMed
99. Gupta S, Swanson AA, Chen YB, Lopez T, Milosevic D, Kipp BR, Leibovich BC, Thompson RH, Herrera-Hernandez L, Cheville JC, Jimenez RE. Incidence of succinate dehydrogenase and fumarate hydratase-deficient renal cell carcinoma based on immunohistochemical screening with SDHA/SDHB and FH/2SC. Hum Pathol. 2019 Sep; 91:114-122 Epub 2019 July 09
    View PubMed
100. Andrews JR, Atwell T, Schmit G, Lohse CM, Kurup AN, Weisbrod A, Callstrom MR, Cheville JC, Boorjian SA, Leibovich BC, Thompson RH. Oncologic Outcomes Following Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses. Eur Urol. 2019 Aug; 76 (2):244-251 Epub 2019 May 03
     View PubMed
101. Lyon TD, Frank I, Sharma V, Shah PH, Tollefson MK, Thompson RH, Karnes RJ, Thapa P, Cheville JC, Boorjian SA. A risk-stratified approach to neoadjuvant chemotherapy in muscle-invasive bladder cancer: implications for patients classified with low-risk disease. World J Urol. 2019 Aug; 37 (8):1605-1613 Epub 2018 Nov 03
     View PubMed
102. Rieken M, Boorjian SA, Kluth LA, Capitanio U, Briganti A, Thompson RH, Leibovich BC, Krabbe LM, Margulis V, Raman JD, Regelman M, Karakiewicz PI, Roupret M, Abufaraj M, Foerster B, Gonen M, Shariat SF. Development and external validation of a pathological nodal staging score for patients with clear cell renal cell carcinoma. World J Urol. 2019 Aug; 37 (8):1631-1637 Epub 2018 Nov 07
     View PubMed
103. Denic A, Ricaurte L, Lopez CL, Narasimhan R, Lerman LO, Lieske JC, Thompson RH, Kremers WK, Rule AD. Glomerular Volume and Glomerulosclerosis at Different Depths within the Human Kidney. J Am Soc Nephrol. 2019 Aug; 30 (8):1471-1480 Epub 2019 July 05
     View PubMed
104. Shah PH, Leibovich BC, Van Houten H, Lyon TD, Yao X, Knoedler M, Sangaralingham L, Kattah A, Thompson RH, Shah ND, Boorjian SA. Association of Partial versus Radical Nephrectomy with Subsequent Hypertension Risk Following Renal Tumor Resection. J Urol. 2019 Jul; 202 (1):69-75 Epub 2019 June 07
     View PubMed
105. Boeri L, Soligo M, Frank I, Boorjian SA, Thompson RH, Tollefson M, Quevedo FJ, Cheville JC, Karnes RJ. Delaying Radical Cystectomy After Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer is Associated with Adverse Survival Outcomes. Eur Urol Oncol. 2019 Jul; 2 (4):390-396 Epub 2018 Sept 28
     View PubMed
106. Boeri L, Soligo M, Frank I, Boorjian SA, Thompson RH, Tollefson M, Quevedo FJ, Cheville JC, Karnes RJ. Cigarette smoking is associated with adverse pathological response and increased disease recurrence amongst patients with muscle-invasive bladder cancer treated with cisplatin-based neoadjuvant chemotherapy and radical cystectomy: a single-centre experience. BJU Int. 2019 Jun; 123 (6):1011-1019 Epub 2019 Jan 08
     View PubMed
107. Westerman ME, Sharma V, Bailey GC, Boorjian SA, Frank I, Gettman MT, Thompson RH, Tollefson MK, Karnes RJ. Impact of time from biopsy to surgery on complications, functional and oncologic outcomes following radical prostatectomy. Int Braz J Urol. 2019 May-Jun; 45 (3):468-477
     View PubMed
108. Bhindi B, Lohse CM, Schulte PJ, Mason RJ, Cheville JC, Boorjian SA, Leibovich BC, Thompson RH. Predicting Renal Function Outcomes After Partial and Radical Nephrectomy. Eur Urol. 2019 May; 75 (5):766-772 Epub 2018 Nov 23
     View PubMed
109. Boswell TC, Sharma V, Westerman ME, Dean PG, Chow GK, Thompson RH, Leibovich BC, Boorjian SA. Frequency and Predictors of Renal Transplantation Among Patients Rendered Surgically Anephric for Sporadic Renal Cancer. Urology. 2019 Apr; 126:134-139 Epub 2019 Jan 12
     View PubMed
110. Lyon TD, Boorjian SA, Shah PH, Tarrell R, Cheville JC, Frank I, Karnes RJ, Thompson RH, Tollefson MK. Comprehensive characterization of perioperative reoperation following radical cystectomy. Urol Oncol. 2019 Apr; 37 (4):292.e11-292.e17 Epub 2019 Jan 22
     View PubMed
111. Shenoy N, Bhagat TD, Cheville J, Lohse C, Bhattacharyya S, Tischer A, Machha V, Gordon-Mitchell S, Choudhary G, Wong LF, Gross L, Ressigue E, Leibovich B, Boorjian SA, Steidl U, Wu X, Pradhan K, Gartrell B, Agarwal B, Pagliaro L, Suzuki M, Greally JM, Rakheja D, Thompson RH, Susztak K, Witzig T, Zou Y, Verma A. Ascorbic acid-induced TET activation mitigates adverse hydroxymethylcytosine loss in renal cell carcinoma. J Clin Invest. 2019 Mar 4; 129 (4):1612-1625 Epub 2019 Mar 04
     View PubMed
112. Atwell TD, Schultz GG, Leibovich BC, Schmit GD, Boorjian SA, Kurup AN, Thompson RH, Yost KJ. Patient-Reported Outcomes After Percutaneous Renal Ablation: Initial Experience. AJR Am J Roentgenol. 2019 Mar; 212 (3):672-676 Epub 2019 Jan 08
     View PubMed
113. Shah PH, Lyon TD, Lohse CM, Cheville JC, Leibovich BC, Boorjian SA, Thompson RH. Prognostic evaluation of perinephric fat, renal sinus fat, and renal vein invasion for patients with pathological stage T3a clear-cell renal cell carcinoma. BJU Int. 2019 Feb; 123 (2):270-276 Epub 2018 Sept 09
     View PubMed
114. Thompson RH, Lohse CM, Husmann DA, Leibovich BC, Gettman MT. Predictors of Urology Resident Surgical Skills, Clinical Communication Skills, Common Sense and In-Service Scores. Urol Pract. 2019 Jan; 6 (1):52-57 Epub 2017 Dec 29
     View PubMed
115. Thompson SM, Schmitz JJ, Thompson RH, Weisbrod AJ, Welch BT, Viers BR, Hannon JD, Schmit GD, Atwell TD, Kurup AN. Introduction of Microwave Ablation Into a Renal Ablation Practice: Valuable Lessons Learned. AJR Am J Roentgenol. 2018 Dec; 211 (6):1381-1389 Epub 2018 Sept 24
     View PubMed
116. Gershman B, Thompson RH, Boorjian SA, Lohse CM, Costello BA, Cheville JC, Leibovich BC. Radical Versus Partial Nephrectomy for cT1 Renal Cell Carcinoma. Eur Urol. 2018 Dec; 74 (6):825-832 Epub 2018 Sept 24
     View PubMed
117. Shenoy N, Mudireddy M, Vallapureddy R, Leung N, Pagliaro L, Witzig T, Ou FS, Ordog T, Cheville J, Patnaik M, Thompson RH, Tefferi A, Begna K. Association Between Renal Cell Carcinoma and Myelodysplastic Syndromes: Epigenetic Underpinning? Clin Genitourin Cancer. 2018 Dec; 16 (6):e1117-e1122 Epub 2018 June 28
     View PubMed
118. Lyon TD, Gershman B, Shah PH, Thompson RH, Boorjian SA, Lohse CM, Costello BA, Cheville JC, Leibovich BC. Risk prediction models for cancer-specific survival following cytoreductive nephrectomy in the contemporary era. Urol Oncol. 2018 Nov; 36 (11):499.e1-499.e7 Epub 2018 Sept 15
     View PubMed
119. Lyon TD, Frank I, Shah PH, Tarrell R, Cheville JC, Karnes RJ, Thompson RH, Tollefson MK, Boorjian SA. The Association of Aspirin Use with Survival Following Radical Cystectomy. J Urol. 2018 Nov; 200 (5):1014-1021 Epub 2018 May 30
     View PubMed
120. Shah PH, Alom MA, Leibovich BC, Thompson RH, Uzzo RG, Kavoussi LR, Richstone L, Bhindi B, Habermann EB, Joshi V, Boorjian SA. The Temporal Association of Robotic Surgical Diffusion with Overtreatment of the Small Renal Mass. J Urol. 2018 Nov; 200 (5):981-988 Epub 2018 May 22
     View PubMed
121. Moschini M, Sharma V, Soligo M, Psutka S, Rangel L, Boorjian SA, Frank I, Gettman MT, Thompson RH, Tollefson MK, Karnes RJ. Heterogeneity of risk within Gleason 4 + 4, 4 + 5 and 5 + 4 prostate cancer. Scand J Urol. 2018 Oct - Dec; 52 (5-6):340-348 Epub 2019 Jan 02
     View PubMed
122. Salagierski M, Wojciechowska A, Zajac K, Klatte T, Thompson RH, Cadeddu JA, Kaouk J, Autorino R, Ahrar K, Capitanio U, Young Academic Urologists Kidney Cancer Working Group of the European Urological Association. The Role of Ablation and Minimally Invasive Techniques in the Management of Small Renal Masses. Eur Urol Oncol. 2018 Oct; 1 (5):395-402 Epub 2018 Sept 24
     View PubMed
123. Bhindi B, Thompson RH, Lohse CM, Mason RJ, Frank I, Costello BA, Potretzke AM, Hartman RP, Potretzke TA, Boorjian SA, Cheville JC, Leibovich BC. The Probability of Aggressive Versus Indolent Histology Based on Renal Tumor Size: Implications for Surveillance and Treatment. Eur Urol. 2018 Oct; 74 (4):489-497 Epub 2018 July 13
     View PubMed
124. Thompson RH, Lohse CM, Husmann DA, Leibovich BC, Gettman MT. Predictors of Scholarly Productivity, Pursuit of Fellowship, and Academic Practice Among Urology Residents Using Medical Student Application Materials. Urology. 2018 Oct; 120:49-55 Epub 2018 July 19
     View PubMed
125. Eiken PW, Atwell TD, Kurup AN, Boorjian SA, Thompson RH, Schmit GD. Imaging following renal ablation: what can we learn from recurrent tumors? Abdom Radiol (NY). 2018 Oct; 43 (10):2750-2755
     View PubMed
126. Bhindi B, Habermann EB, Mason RJ, Costello BA, Pagliaro LC, Thompson RH, Leibovich BC, Boorjian SA. Comparative Survival following Initial Cytoreductive Nephrectomy versus Initial Targeted Therapy for Metastatic Renal Cell Carcinoma. J Urol. 2018 Sep; 200 (3):528-534 Epub 2018 Mar 21
     View PubMed
127. Shah PH, Thompson RH, Boorjian SA, Lohse CM, Lyon TD, Shields RC, Froehling D, Leibovich BC, Viers BR. Symptomatic Venous Thromboembolism is Associated with Inferior Survival among Patients Undergoing Nephrectomy with Inferior Vena Cava Tumor Thrombectomy for Renal Cell Carcinoma. J Urol. 2018 Sep; 200 (3):520-527 Epub 2018 Apr 27
     View PubMed
128. Mason RJ, Atwell T, Lohse C, Bhindi B, Schmit G, Schmitz J, Leibovich BC, Boorjian SA, Thompson RH. Synchronous nephron-sparing approaches for bilateral renal masses: peri-operative and renal functional outcomes. BJU Int. 2018 Aug; 122 (2):243-248 Epub 2018 Apr 29
     View PubMed
129. Lyon TD, Tollefson MK, Shah PH, Bews K, Frank I, Karnes RJ, Thompson RH, Habermann EB, Boorjian SA. Temporal trends in venous thromboembolism after radical cystectomy. Urol Oncol. 2018 Aug; 36 (8):361.e15-361.e21 Epub 2018 June 07
     View PubMed
130. Haddad MM, Schmit GD, Kurup AN, Schmitz JJ, Boorjian SA, Geske J, Thompson RH, Callstrom MR, Atwell TD. Percutaneous Cryoablation of Solitary, Sporadic Renal Cell Carcinoma: Outcome Analysis Based on Clear-Cell versus Papillary Subtypes. J Vasc Interv Radiol. 2018 Aug; 29 (8):1122-1126 Epub 2018 June 07
     View PubMed
131. Denic A, Mathew J, Nagineni VV, Thompson RH, Leibovich BC, Lerman LO, Lieske JC, Alexander MP, Augustine JJ, Kremers WK, Rule AD. Clinical and Pathology Findings Associate Consistently with Larger Glomerular Volume. J Am Soc Nephrol. 2018 Jul; 29 (7):1960-1969 Epub 2018 May 22
     View PubMed
132. Schmit CH, Callstrom MR, Boorjian SA, Johnson MP, Atwell TD, Kurup AN, Schultz GR, Thompson RH, Schmit GD. A Comparison of Bleeding Complications in Patients Undergoing Percutaneous Renal Cryoablation Using Cryoprobes with and without Heat-Based Track Ablation. J Vasc Interv Radiol. 2018 Jun; 29(6):874-879. Epub 2018 Mar 03.
     View PubMed
133. Gershman B, Thompson RH, Boorjian SA, Larcher A, Capitanio U, Montorsi F, Carenzi C, Bertini R, Briganti A, Lohse CM, Cheville JC, Leibovich BC. Radical Nephrectomy with or without Lymph Node Dissection for High Risk Nonmetastatic Renal Cell Carcinoma: A Multi-Institutional Analysis. J Urol. 2018 May; 199 (5):1143-1148 Epub 2017 Dec 07
     View PubMed
134. Hutchinson R, Rew C, Chen G, Woldu S, Krabbe LM, Meissner M, Sheth K, Singla N, Shakir N, Master VA, Karam JA, Matin SF, Borregales LD, Wood C, Masterson T, Thompson RH, Boorjian SA, Leibovich BC, Abel EJ, Bagrodia A, Margulis V. The Adverse Survival Implications of Bland Thrombus in Renal Cell Carcinoma With Venous Tumor Thrombus. Urology. 2018 May; 115:119-124 Epub 2018 Feb 27
     View PubMed
135. Bhindi B, Wallis CJD, Boorjian SA, Thompson RH, Farrell A, Kim SP, Karam JA, Capitanio U, Golijanin D, Leibovich BC, Gershman B. The role of lymph node dissection in the management of renal cell carcinoma: a systematic review and meta-analysis. BJU Int. 2018 May; 121 (5):684-698 Epub 2018 Mar 01
     View PubMed
136. Leibovich BC, Lohse CM, Cheville JC, Zaid HB, Boorjian SA, Frank I, Thompson RH, Parker WP. Predicting Oncologic Outcomes in Renal Cell Carcinoma After Surgery. Eur Urol. 2018 May; 73 (5):772-780 Epub 2018 Feb 03
     View PubMed
137. Kocher JP, Sun Q, Wu Y, Miller M, Zhang W, Wang J, Zhang J, Wong T, Lee S, Zhao F, Anderson ML, Brat DJ, Olson JJ, Sica G, Ahn K, Bell D, Borad M, Bryce AH, Castle E, Chandan V, Cheville J, Copland JA, Farnell M, Flotte T, Giama N, Ho T, Nagorney D, O'Brien D, O'Neill BP, Patel T, Petersen G, Que F, Rivera M, Roberts L, Smallridge R, Smyrk T, Stanton M, Thompson RH, Torbenson M, Zhang L, Guo C, Haydu L, Quinn M, Dhanasekaran R, Nguyen P, Peterson L, Knijnenburg TA, Wang L, Zimmermann MT, Chambwe N, Gao GF, Cherniack AD, Fan H, Shen H, Way GP, Greene CS, Liu Y, Akbani R, Feng B, Donehower LA, Miller C, Shen Y, Karimi M, Chen H, Kim P, Jia P, Shinbrot E, Zhang S, Liu J, Hu H, Bailey MH, Yau C, Wolf D, Zhao Z, Weinstein JN, Li L, Ding L, Mills GB, Laird PW, Wheeler DA, Shmulevich I, Monnat RJ Jr, Xiao Y, Wang C, Cancer Genome Atlas Research Network. Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas. Cell Rep. 2018 Apr 3; 23 (1):239-254.e6
     View PubMed
138. Zabor EC, Furberg H, Lee B, Campbell S, Lane BR, Thompson RH, Antonio EC, Noyes SL, Zaid H, Jaimes EA, Russo P. Long-Term Renal Function Recovery following Radical Nephrectomy for Kidney Cancer: Results from a Multicenter Confirmatory Study. J Urol. 2018 Apr; 199 (4):921-926 Epub 2017 Oct 21
     View PubMed
139. Mir MC, Matin SF, Bex A, Spiess PE, Thompson RH, Grob B, van Poppel H. The role of surgery in the management of metastatic kidney cancer: an evidence-based collaborative review. Minerva Urol Nefrol. 2018 Apr; 70 (2):109-125 Epub 2018 Jan 29
     View PubMed
140. Gershman B, Moreira DM, Thompson RH, Boorjian SA, Lohse CM, Costello BA, Cheville JC, Leibovich BC. Perioperative Morbidity of Lymph Node Dissection for Renal Cell Carcinoma: A Propensity Score-based Analysis. Eur Urol. 2018 Mar; 73 (3):469-475 Epub 2017 Nov 11
     View PubMed
141. Bhindi B, Mason RJ, Haddad MM, Boorjian SA, Leibovich BC, Atwell TD, Weisbrod AJ, Schmit GD, Thompson RH. Outcomes After Cryoablation Versus Partial Nephrectomy for Sporadic Renal Tumors in a Solitary Kidney: A Propensity Score Analysis. Eur Urol. 2018 Feb; 73 (2):254-259 Epub 2017 Sept 28
     View PubMed
142. Morlacco A, Murphy CR, Rangel LJ, Mynderse LA, Thompson RH, Karnes RJ. Effect of Level of Urology Training on Gleason Score and Prostate Volume Estimation Agreement between Transrectal Ultrasound Guided Biopsy and Radical Prostatectomy Specimen. Urol Pract. 2018 Jan; 5 (1):76-82 Epub 2016 Dec 07
     View PubMed
143. Merrill SB, Boorjian SA, Thompson RH, Psutka SP, Cheville JC, Thapa P, Tollefson MK, Frank I. Oncologic surveillance following radical cystectomy: an individualized risk-based approach. World J Urol. 2017 Dec; 35 (12):1863-1869 Epub 2017 July 06
     View PubMed
144. Bhindi B, Karnes RJ, Rangel LJ, Mason RJ, Gettman MT, Frank I, Tollefson MK, Lin DW, Thompson RH, Boorjian SA. Independent Validation of the American Joint Committee on Cancer 8th Edition Prostate Cancer Staging Classification. J Urol. 2017 Dec; 198 (6):1286-1294 Epub 2017 June 29
     View PubMed
145. Atwell TD, Kurup AN, Boorjian SA, Schmitz JJ, Thompson RH, Leibovich BC, Schmit GD. Percutaneous Cryoablation of Renal Cell Carcinoma with Sinus Vein Involvement Based on Preprocedural Imaging. J Vasc Interv Radiol. 2017 Dec; 28 (12):1651-1657 Epub 2017 Oct 16
     View PubMed
146. Mason RJ, Frank I, Bhindi B, Tollefson MK, Thompson RH, Karnes RJ, Tarrell R, Thapa P, Boorjian SA. Radical cystectomy for recurrent urothelial carcinoma after prior partial cystectomy: perioperative and oncologic outcomes. World J Urol. 2017 Dec; 35 (12):1879-1884 Epub 2017 Sept 14
     View PubMed
147. Bertolo RG, Zargar H, Autorino R, Fiori C, Kaouk JH, Russo P, Thompson RH, Porpiglia F. Estimated glomerular filtration rate, renal scan and volumetric assessment of the kidney before and after partial nephrectomy: a review of the current literature. Minerva Urol Nefrol. 2017 Dec; 69 (6):539-547 Epub 2017 June 23
     View PubMed
148. Ho TH, Kapur P, Eckel-Passow JE, Christie A, Joseph RW, Serie DJ, Cheville JC, Thompson RH, Homayoun F, Panwar V, Brugarolas J, Parker AS. Multicenter Validation of Enhancer of Zeste Homolog 2 Expression as an Independent Prognostic Marker in Localized Clear Cell Renal Cell Carcinoma. J Clin Oncol. 2017 Nov 10; 35 (32):3706-3713 Epub 2017 Oct 04
     View PubMed
149. Bhindi B, Carlson RE, Mason RJ, Schulte PJ, Gettman MT, Frank I, Tollefson MK, Thompson RH, Boorjian SA, Leibovich BC, Karnes RJ. Long-term Follow-up of a Matched Cohort Study Evaluating the Role of Adjuvant Radiotherapy for Organ-confined Prostate Cancer With a Positive Surgical Margin. Urology. 2017 Nov; 109:145-152 Epub 2017 Aug 18
     View PubMed
150. Bhindi B, Frank I, Mason RJ, Tarrell RF, Thapa P, Cheville JC, Costello BA, Pagliaro LC, Karnes RJ, Thompson RH, Tollefson MK, Boorjian SA. Oncologic Outcomes for Patients with Residual Cancer at Cystectomy Following Neoadjuvant Chemotherapy: A Pathologic Stage-matched Analysis. Eur Urol 2017 Nov; 72 (5):660-664 Epub 2017 May 22
     View PubMed
151. Bhindi B, Lohse CM, Mason RJ, Westerman ME, Cheville JC, Tollefson MK, Boorjian SA, Thompson RH, Leibovich BC. Are We Using the Best Tumor Size Cut-points for Renal Cell Carcinoma Staging? Urology. 2017 Nov; 109:121-126 Epub 2017 Apr 12
     View PubMed
152. Thompson RH, Lohse CM, Husmann DA, Leibovich BC, Gettman MT. Predictors of a Successful Urology Resident Using Medical Student Application Materials. Urology. 2017 Oct; 108:22-28 Epub 2017 July 24
     View PubMed
153. Mason RJ, Atwell TD, Lohse C, Bhindi B, Weisbrod A, Boorjian SA, Leibovich BC, Schmit GD, Thompson RH. Renal functional outcomes in patients undergoing percutaneous cryoablation or partial nephrectomy for a solitary renal mass. BJU Int. 2017 Oct; 120 (4):544-549 Epub 2017 June 19
     View PubMed
154. Yang DY, Thompson RH, Zaid HB, Lohse CM, Rule AD, Boorjian SA, Leibovich BC, Cheville JC, Tollefson MK. Severity of Preoperative Proteinuria is a Risk Factor for Overall Mortality in Patients Undergoing Nephrectomy. J Urol. 2017 Oct; 198 (4):795-802 Epub 2017 Apr 08
     View PubMed
155. Gershman B, Moreira DM, Thompson RH, Boorjian SA, Lohse CM, Costello BA, Cheville JC, Leibovich BC. Renal Cell Carcinoma with Isolated Lymph Node Involvement: Long-term Natural History and Predictors of Oncologic Outcomes Following Surgical Resection. Eur Urol. 2017 Aug; 72 (2):300-306 Epub 2017 Jan 13
     View PubMed
156. Parker WP, Smelser W, Lee EK, Habermann EB, Thapa P, Zaid HB, Frank I, Griebling TL, Tollefson MK, Thompson RH, Holzbeierlein JM, Karnes RJ, Boorjian SA. Utilization and Outcomes of Radical Cystectomy for High-grade Non-muscle-invasive Bladder Cancer in Elderly Patients. Clin Genitourin Cancer. 2017 Aug 1 Epub 2017 Aug 01
     View PubMed
157. Parker WP, Habermann EB, Day CN, Zaid HB, Frank I, Thompson RH, Tollefson MK, Boorjian SA, Pagliaro LC, Karnes RJ. Adverse Pathology After Neoadjuvant Chemotherapy and Radical Cystectomy: The Role of Adjuvant Chemotherapy. Clin Genitourin Cancer. 2017 Jul 22 Epub 2017 July 22
     View PubMed
158. Gupta S, Johnson SH, Vasmatzis G, Porath B, Rustin JG, Rao P, Costello BA, Leibovich BC, Thompson RH, Cheville JC, Sukov WR. TFEB-VEGFA (6p21.1) co-amplified renal cell carcinoma: a distinct entity with potential implications for clinical management. Mod Pathol. 2017 Jul; 30 (7):998-1012 Epub 2017 Mar 24
     View PubMed
159. Bhindi B, Rangel LJ, Mason RJ, Gettman MT, Frank I, Kwon ED, Tollefson MK, Thompson RH, Boorjian SA, Karnes RJ. Impact of Radical Prostatectomy on Long-Term Oncologic Outcomes in a Matched Cohort of Men with Pathological Node Positive Prostate Cancer Managed by Castration. J Urol. 2017 Jul; 198 (1):86-91 Epub 2017 Jan 24
     View PubMed
160. Casuscelli J, Weinhold N, Gundem G, Wang L, Zabor EC, Drill E, Wang PI, Nanjangud GJ, Redzematovic A, Nargund AM, Manley BJ, Arcila ME, Donin NM, Cheville JC, Thompson RH, Pantuck AJ, Russo P, Cheng EH, Lee W, Tickoo SK, Ostrovnaya I, Creighton CJ, Papaemmanuil E, Seshan VE, Hakimi AA, Hsieh JJ. Genomic landscape and evolution of metastatic chromophobe renal cell carcinoma. JCI Insight. 2017 Jun 15; 2 (12) Epub 2017 June 15
     View PubMed
161. Serie DJ, Joseph RW, Cheville JC, Ho TH, Parasramka M, Hilton T, Thompson RH, Leibovich BC, Parker AS, Eckel-Passow JE. Clear Cell Type A and B Molecular Subtypes in Metastatic Clear Cell Renal Cell Carcinoma: Tumor Heterogeneity and Aggressiveness. Eur Urol. 2017 Jun; 71 (6):979-985 Epub 2016 Nov 26
     View PubMed
162. Bhindi B, Thompson RH, Mason RJ, Haddad MM, Geske JR, Kurup AN, Hannon JD, Boorjian SA, Leibovich BC, Atwell TD, Schmit GD. Comprehensive assessment of renal tumour complexity in a large percutaneous cryoablation cohort. BJU Int. 2017 Jun; 119 (6):905-912 Epub 2017 Apr 09
     View PubMed
163. Gershman B, Thompson RH, Moreira DM, Boorjian SA, Tollefson MK, Lohse CM, Costello BA, Cheville JC, Leibovich BC. Radical Nephrectomy With or Without Lymph Node Dissection for Nonmetastatic Renal Cell Carcinoma: A Propensity Score-based Analysis. Eur Urol. 2017 Apr; 71 (4):560-567 Epub 2016 Sept 24
     View PubMed
164. Bailey GC, Boorjian SA, Ziegelmann MJ, Westerman ME, Lohse CM, Leibovich BC, Cheville JC, Thompson RH. Urinary collecting system invasion is associated with poor survival in patients with clear-cell renal cell carcinoma. BJU Int. 2017 Apr; 119 (4):585-590 Epub 2016 Oct 20
     View PubMed
165. Parker WP, Cheville JC, Frank I, Zaid HB, Lohse CM, Boorjian SA, Leibovich BC, Thompson RH. Application of the Stage, Size, Grade, and Necrosis (SSIGN) Score for Clear Cell Renal Cell Carcinoma in Contemporary Patients. Eur Urol. 2017 Apr; 71 (4):665-673 Epub 2016 June 07
     View PubMed
166. Muppa P, Gupta S, Frank I, Boorjian SA, Karnes RJ, Thompson RH, Thapa P, Tarrell RF, Herrera Hernandez LP, Jimenez RE, Cheville JC. Prognostic significance of lymphatic, vascular and perineural invasion for bladder cancer patients treated by radical cystectomy. Pathology. 2017 Apr; 49(3):259-266. Epub 2017 Mar 01.
     View PubMed
167. Huang J, Atwell TD, Kurup AN, Boorjian SA, Thompson RH, Schmit GD. Percutaneous Cryoablation of the Horseshoe Kidney: An Initial Experience. J Vasc Interv Radiol. 2017 Apr; 28 (4):498-501
     View PubMed
168. Zaid HB, Parker WP, Lohse CM, Cheville JC, Boorjian SA, Leibovich BC, Thompson RH. Patient factors associated with 30-day complications after partial nephrectomy: A contemporary update. Urol Oncol. 2017 Apr; 35 (4):153.e1-153.e6 Epub 2016 Dec 06
     View PubMed
169. Eckel-Passow JE, Serie DJ, Cheville JC, Ho TH, Kapur P, Brugarolas J, Thompson RH, Leibovich BC, Kwon ED, Joseph RW, Parker AS. BAP1 and PBRM1 in metastatic clear cell renal cell carcinoma: tumor heterogeneity and concordance with paired primary tumor. BMC Urol. 2017 Mar 21; 17 (1):19
     View PubMed
170. Gershman B, Thompson RH, Moreira DM, Boorjian SA, Lohse CM, Costello BA, Cheville JC, Leibovich BC. Lymph Node Dissection is Not Associated with Improved Survival among Patients Undergoing Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma: A Propensity Score Based Analysis. J Urol. 2017 Mar; 197 (3 Pt 1):574-579 Epub 2016 Sept 20
     View PubMed
171. Finelli A, Ismaila N, Bro B, Durack J, Eggener S, Evans A, Gill I, Graham D, Huang W, Jewett MA, Latcha S, Lowrance W, Rosner M, Shayegan B, Thompson RH, Uzzo R, Russo P. Management of Small Renal Masses: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol. 2017 Feb 20; 35: (6)668-680.
     View PubMed
172. Parker WP, Lohse CM, Zaid HB, Cheville JC, Boorjian SA, Leibovich BC, Thompson RH. Evaluation of beta-blockers and survival among hypertensive patients with renal cell carcinoma. Urol Oncol. 2017 Jan; 35 (1):36.e1-36.e6 Epub 2016 Sept 27
     View PubMed
173. Zaid HB, Parker WP, Safdar NS, Gershman B, Erwin PJ, Murad MH, Boorjian SA, Costello BA, Thompson RH, Leibovich BC. Outcomes Following Complete Surgical Metastasectomy for Patients with Metastatic Renal Cell Carcinoma: A Systematic Review and Meta-Analysis. J Urol. 2017 Jan; 197 (1):44-49 Epub 2016 July 26
     View PubMed
174. Psutka SP, Heidenreich M, Boorjian SA, Bailey GC, Cheville JC, Stewart-Merrill SB, Lohse CM, Atwell TD, Costello BA, Leibovich BC, Thompson RH. Renal fossa recurrence after nephrectomy for renal cell carcinoma: prognostic features and oncological outcomes. BJU Int. 2017 Jan; 119 (1):116-127 Epub 2016 Aug 31
     View PubMed
175. Joyce DD, Psutka SP, Groeschl RT, Thompson RH, Boorjian SA, Cheville JC, Stewart-Merrill SB, Lohse CM, Costello BA, Que FG, Leibovich BC. Complications and Outcomes Associated With Surgical Management of Renal Cell Carcinoma Involving the Liver: A Matched Cohort Study. Urology. 2017 Jan; 99:155-161 Epub 2016 Aug 17
     View PubMed
176. Parasramka M, Serie DJ, Asmann YW, Eckel-Passow JE, Castle EP, Stanton ML, Leibovich BC, Thompson RH, Thompson EA, Parker AS, Ho TH, Joseph RW. Validation of Gene Expression Signatures to Identify Low-risk Clear-cell Renal Cell Carcinoma Patients at Higher Risk for Disease-related Death. Eur Urol Focus. 2016 Dec 15; 2 (6):608-615 Epub 2016 Apr 02
     View PubMed
177. Parker WP, Boorjian SA, Zaid HB, Cheville JC, Leibovich BC, Thompson RH. Surgical Management and Oncologic Outcomes of Recurrent Venous Tumor Thrombus after Prior Nephrectomy for Renal Cell Carcinoma. Eur Urol Focus. 2016 Dec 15; 2 (6):625-630 Epub 2016 July 07
     View PubMed
178. Viers BR, Thompson RH, Lohse CM, Cheville JC, Leibovich BC, Boorjian SA, Tollefson MK. Pre-treatment neutrophil-to-lymphocyte ratio predicts tumor pathology in newly diagnosed renal tumors. World J Urol. 2016 Dec; 34 (12):1693-1699 Epub 2016 Apr 06
     View PubMed
179. Parker WP, Tollefson MK, Heins CN, Hanson KT, Hanson KT, Habermann EB, Zaid HB, Frank I, Thompson RH, Boorjian SA. Characterization of perioperative infection risk among patients undergoing radical cystectomy: Results from the national surgical quality improvement program. Urol Oncol. 2016 Dec; 34 (12):532.e13-532.e19 Epub 2016 Aug 05
     View PubMed
180. Gershman B, Takahashi N, Moreira DM, Thompson RH, Boorjian SA, Lohse CM, Costello BA, Cheville JC, Leibovich BC. Radiographic size of retroperitoneal lymph nodes predicts pathological nodal involvement for patients with renal cell carcinoma: development of a risk prediction model. BJU Int. 2016 Nov; 118 (5):742-749 Epub 2016 Feb 23
     View PubMed
181. Westerman ME, Parker WP, Viers BR, Rivera ME, Karnes RJ, Frank I, Tarrell R, Thapa P, Thompson RH, Tollefson MK, Boorjian SA. Malignant ureteroenteric anastomotic stricture following radical cystectomy with urinary diversion: Patterns, risk factors, and outcomes. Urol Oncol. 2016 Nov; 34(11):485.e1-485.e6. Epub 2016 Jul 14.
     View PubMed
182. Zaid HB, Yang DY, Tollefson MK, Frank I, Parker WP, Thompson RH, Karnes RJ, Boorjian SA. Safety and Efficacy of Extended Duration of Thromboembolic Prophylaxis Following Radical Cystectomy: An Initial Institutional Experience. Urol Pract. 2016 Nov; 3 (6):462-467 Epub 2016 Aug 18
     View PubMed
183. Moreira DM, Gershman B, Lohse CM, Boorjian SA, Cheville JC, Leibovich BC, Thompson RH. Paraneoplastic syndromes are associated with adverse prognosis among patients with renal cell carcinoma undergoing nephrectomy. World J Urol. 2016 Oct; 34 (10):1465-72 Epub 2016 Feb 25
     View PubMed
184. Psutka SP, Cheville JC, Costello BA, Stewart-Merrill SB, Lohse CM, Leibovich BC, Boorjian SA, Thompson RH. Concordance of Pathologic Features Between Metastatic Sites and the Primary Tumor in Surgically Resected Metastatic Renal Cell Carcinoma. Urology. 2016 Oct; 96:106-113 Epub 2016 July 21
     View PubMed
185. Moreira DM, Gershman B, Rangel LJ, Boorjian SA, Thompson RH, Frank I, Tollefson MK, Gettman MT, Karnes RJ. Evaluation of pT0 prostate cancer in patients undergoing radical prostatectomy. BJU Int. 2016 Sep; 118: (3)379-83.
     View PubMed
186. Westerman ME, Gershman B, Karnes RJ, Thompson RH, Rangel L, Boorjian SA. Impact of a family history of prostate cancer on clinicopathologic outcomes and survival following radical prostatectomy. World J Urol. 2016 Aug; 34 (8):1115-22 Epub 2015 Dec 09
     View PubMed
187. Parker WP, Toussi A, Tollefson MK, Frank I, Thompson RH, Zaid HB, Thapa P, Boorjian SA. Risk Factors and Microbial Distribution of Urinary Tract Infections Following Radical Cystectomy. Urology. 2016 Aug; 94:96-101. Epub 2016 Apr 25.
     View PubMed
188. Zaid HB, Yang DY, Tollefson MK, Frank I, Winters JL, Thapa P, Parker WP, Thompson RH, Karnes RJ, Boorjian SA. Efficacy and Safety of Intraoperative Tranexamic Acid Infusion for Reducing Blood Transfusion During Open Radical Cystectomy. Urology. 2016 Jun; 92:57-62. Epub 2016 Mar 08.
     View PubMed
189. Toussi A, Stewart-Merrill SB, Boorjian SA, Psutka SP, Thompson RH, Frank I, Tollefson MK, Gettman MT, Carlson RE, Rangel LJ, Karnes RJ. Standardizing the Definition of Biochemical Recurrence after Radical Prostatectomy-What Prostate Specific Antigen Cut Point Best Predicts a Durable Increase and Subsequent Systemic Progression? J Urol. 2016 Jun; 195(6):1754-9. Epub 2015 Dec 23.
     View PubMed
190. Moschini M, Sharma V, Zattoni F, Boorjian SA, Frank I, Gettman MT, Thompson RH, Tollefson MK, Kwon ED, Karnes RJ. Risk Stratification of pN+ Prostate Cancer after Radical Prostatectomy from a Large Single Institutional Series with Long-Term Followup. J Urol. 2016 Jun; 195 (6):1773-8 Epub 2015 Dec 23
     View PubMed
191. Schmit GD, Thompson RH, Buttar NS. Colorenal Fistula Repair Using a Combined Percutaneous CT-Guided and Endoscopic Approach. J Vasc Interv Radiol. 2016 Jun; 27: (6)896-7.
     View PubMed
192. Russell CM, Lue K, Fisher J, Kassouf W, Schwaab T, Sexton WJ, Tanguay S, Psutka SP, Thompson RH, Leibovich BC, Hanzly MI, Spiess PE, Boorjian SA. Oncological control associated with surgical resection of isolated retroperitoneal lymph node recurrence of renal cell carcinoma. BJU Int. 2016 Jun; 117: (6B)E60-6.
     View PubMed
193. Karam JA, Devine CE, Fellman BM, Urbauer DL, Abel EJ, Allaf ME, Bex A, Lane BR, Thompson RH, Wood CG. Variability of inter-observer agreement on feasibility of partial nephrectomy before and after neoadjuvant axitinib for locally advanced renal cell carcinoma (RCC): independent analysis from a phase II trial. BJU Int. 2016 Apr; 117 (4):629-35 Epub 2015 June 29
     View PubMed
194. Psutka SP, Boorjian SA, Moynagh MR, Schmit GD, Costello BA, Thompson RH, Stewart-Merrill SB, Lohse CM, Cheville JC, Leibovich BC, Tollefson MK. Decreased Skeletal Muscle Mass is Associated with an Increased Risk of Mortality after Radical Nephrectomy for Localized Renal Cell Cancer. J Urol. 2016 Feb; 195 (2):270-6 Epub 2015 Aug 18
     View PubMed
195. Weight CJ, Mulders PF, Pantuck AJ, Thompson RH. The Role of Adrenalectomy in Renal Cancer. Eur Urol Focus. 2016 Feb; 1 (3):251-257 Epub 2015 Oct 03
     View PubMed
196. Kaushik D, Boorjian SA, Thompson RH, Eisenberg MS, Carlson RE, Bergstralh EJ, Frank I, Gettman MT, Tollefson MK, Karnes RJ. Oncological outcomes following radical prostatectomy for patients with pT4 prostate cancer. Int Braz J Urol. 2016 Nov-Dec; 42(6):1091-1098.
     View PubMed
197. Gershman B, Moreira DM, Tollefson MK, Frank I, Cheville JC, Thapa P, Tarrell RF, Thompson RH, Boorjian SA. The association of ABO blood type with disease recurrence and mortality among patients with urothelial carcinoma of the bladder undergoing radical cystectomy. Urol Oncol. 2016 Jan; 34 (1):4.e1-9 Epub 2015 Aug 29
     View PubMed
198. Zargar H, Atwell TD, Cadeddu JA, de la Rosette JJ, Janetschek G, Kaouk JH, Matin SF, Polascik TJ, Zargar-Shoshtari K, Thompson RH. Cryoablation for Small Renal Masses: Selection Criteria, Complications, and Functional and Oncologic Results. Eur Urol. 2016 Jan; 69 (1):116-28 Epub 2015 Mar 26
     View PubMed
199. Gershman B, Moreira DM, Boorjian SA, Lohse CM, Cheville JC, Costello BA, Leibovich BC, Thompson RH. Comprehensive Characterization of the Perioperative Morbidity of Cytoreductive Nephrectomy. Eur Urol. 2016 Jan; 69 (1):84-91 Epub 2015 June 01
     View PubMed
200. Stewart-Merrill SB, Thompson RH, Boorjian SA, Psutka SP, Lohse CM, Cheville JC, Leibovich BC, Frank I. Oncologic Surveillance After Surgical Resection for Renal Cell Carcinoma: A Novel Risk-Based Approach. J Clin Oncol. 2015 Dec 10; 33 (35):4151-7 Epub 2015 Sept 08
     View PubMed
201. Klatte T, Ficarra V, Gratzke C, Kaouk J, Kutikov A, Macchi V, Mottrie A, Porpiglia F, Porter J, Rogers CG, Russo P, Thompson RH, Uzzo RG, Wood CG, Gill IS. A Literature Review of Renal Surgical Anatomy and Surgical Strategies for Partial Nephrectomy. Eur Urol. 2015 Dec; 68 (6):980-92 Epub 2015 Apr 22
     View PubMed
202. Tabayoyong W, Abouassaly R, Kiechle JE, Cherullo EE, Meropol NJ, Shah ND, Dong S, Thompson RH, Smaldone MC, Zhu H, Ialacci S, Kim SP. Variation in Surgical Margin Status by Surgical Approach among Patients Undergoing Partial Nephrectomy for Small Renal Masses. J Urol. 2015 Dec; 194 (6):1548-53 Epub 2015 June 19
     View PubMed
203. Gupta S, Thompson RH, Boorjian SA, Thapa P, Hernandez LP, Jimenez RE, Costello BA, Frank I, Cheville JC. High grade neuroendocrine carcinoma of the urinary bladder treated by radical cystectomy: a series of small cell, mixed neuroendocrine and large cell neuroendocrine carcinoma. Pathology. 2015 Oct; 47 (6):533-42
     View PubMed
204. Viers BR, Lightner DJ, Rivera ME, Tollefson MK, Boorjian SA, Karnes RJ, Thompson RH, O'Neil DA, Hamilton RL, Gardner MR, Bundrick M, Jenkins SM, Pruthi S, Frank I, Gettman MT. Efficiency, satisfaction, and costs for remote video visits following radical prostatectomy: a randomized controlled trial. Eur Urol. 2015 Oct; 68 (4):729-35 Epub 2015 Apr 18
     View PubMed
205. Psutka SP, Boorjian SA, Thompson RH, Schmit GD, Schmitz JJ, Bower TC, Stewart SB, Lohse CM, Cheville JC, Leibovich BC. Clinical and radiographic predictors of the need for inferior vena cava resection during nephrectomy for patients with renal cell carcinoma and caval tumour thrombus. BJU Int. 2015 Sep; 116 (3):388-96 Epub 2015 Mar 23
     View PubMed
206. Haddad AQ, Leibovich BC, Abel EJ, Luo JH, Krabbe LM, Thompson RH, Heckman JE, Merrill MM, Gayed BA, Sagalowsky AI, Boorjian SA, Wood CG, Margulis V. Preoperative multivariable prognostic models for prediction of survival and major complications following surgical resection of renal cell carcinoma with suprahepatic caval tumor thrombus. Urol Oncol. 2015 Sep; 33: (9)388.e1-9.
     View PubMed
207. Stewart-Merrill SB, Boorjian SA, Thompson RH, Psutka SP, Cheville JC, Thapa P, Bergstrahl EJ, Tollefson MK, Frank I. Evaluation of current surveillance guidelines following radical cystectomy and proposal of a novel risk-based approach. Urol Oncol. 2015 Aug; 33(8):339.e1-8. Epub 2015 May 29.
     View PubMed
208. Zhang BY, Cheville JC, Thompson RH, Lohse CM, Boorjian SA, Leibovich BC, Costello BA. Impact of Rhabdoid Differentiation on Prognosis for Patients with Grade 4 Renal Cell Carcinoma. Eur Urol. 2015 Jul; 68 (1):5-7 Epub 2015 Jan 28
     View PubMed
209. Volpe A, Blute ML, Ficarra V, Gill IS, Kutikov A, Porpiglia F, Rogers C, Touijer KA, Van Poppel H, Thompson RH. Renal Ischemia and Function After Partial Nephrectomy: A Collaborative Review of the Literature. Eur Urol. 2015 Jul; 68 (1):61-74 Epub 2015 Feb 20
     View PubMed
210. Gershman B, Eisenberg MS, Thompson RH, Frank I, Kaushik D, Tarrell R, Thapa P, Boorjian SA. Comparative impact of continent and incontinent urinary diversion on long-term renal function after radical cystectomy in patients with preoperative chronic kidney disease 2 and chronic kidney disease 3a. Int J Urol. 2015 Jul; 22(7):651-6. Epub 2015 Apr 16.
     View PubMed
211. Sobol I, Thompson RH, Dong H, Krco C, Kwon ED. Immunotherapy in prostate cancer. Curr Urol Rep. 2015 Jun; 16 (6):34
     View PubMed
212. Atwell TD, Vlaminck JJ, Boorjian SA, Kurup AN, Callstrom MR, Weisbrod AJ, Lohse CM, Hartman WR, Stockland AH, Leibovich BC, Schmit GD, Thompson RH. Percutaneous cryoablation of stage T1b renal cell carcinoma: technique considerations, safety, and local tumor control. J Vasc Interv Radiol. 2015 Jun; 26 (6):792-9 Epub 2015 Mar 29
     View PubMed
213. Kaushik D, Frank I, Boorjian SA, Cheville JC, Eisenberg MS, Thapa P, Tarrell RF, Thompson RH. Long-term results of radical cystectomy and role of adjuvant chemotherapy for small cell carcinoma of the bladder. Int J Urol. 2015 Jun; 22(6):549-54. Epub 2015 Mar 11.
     View PubMed
214. Miller AJ, Kurup AN, Schmit GD, Weisbrod AJ, Boorjian SA, Thompson RH, Lohse CM, Kor DJ, Callstrom MR, Atwell TD. Percutaneous Clinical T1a Renal Mass Ablation in the Octogenarian and Nonagenarian: Oncologic Outcomes and Morbidity. J Endourol. 2015 Jun; 29 (6):671-6 Epub 2014 Dec 30
     View PubMed
215. Smaldone MC, Handorf E, Kim SP, Thompson RH, Costello BA, Corcoran AT, Wong YN, Uzzo RG, Leibovich BC, Kutikov A, Boorjian SA. Temporal trends and factors associated with systemic therapy after cytoreductive nephrectomy: an analysis of the National Cancer Database. J Urol. 2015 Apr; 193 (4):1108-13 Epub 2014 Oct 23
     View PubMed
216. Welch BT, Brinjikji W, Schmit GD, Kurup AN, El-Sayed AM, Cloft HJ, Thompson RH, Callstrom MR, Atwell TD. Evaluation of the charges, safety, and mortality of percutaneous renal thermal ablation using the nationwide inpatient sample. J Vasc Interv Radiol. 2015 Mar; 26 (3):342-7 Epub 2014 Dec 18
     View PubMed
217. Kim SP, Gross CP, Smaldone MC, Han LC, Van Houten H, Lotan Y, Svatek RS, Thompson RH, Karnes RJ, Trinh QD, Kutikov A, Shah ND. Perioperative outcomes and hospital reimbursement by type of radical prostatectomy: results from a privately insured patient population. Prostate Cancer Prostatic Dis. 2015 Mar; 18 (1):13-7 Epub 2014 Oct 14
     View PubMed
218. Clifton MM, Psutka SP, Boorjian SA, Cheville JC, Thapa P, Thompson RH, Tollefson MK, Karnes RJ, Frank I. Cancer-specific mortality following radical cystectomy for bladder cancer with lymph node involvement: impact of pathologic disease features and adjuvant chemotherapy. World J Urol. 2015 Mar; 33 (3):373-9 Epub 2014 May 15
     View PubMed
219. Zhang BY, Thompson RH, Lohse CM, Leibovich BC, Boorjian SA, Cheville JC, Costello BA. A novel prognostic model for patients with sarcomatoid renal cell carcinoma. BJU Int. 2015 Mar; 115 (3):405-11 Epub 2014 Oct 19
     View PubMed
220. Psutka SP, Kim SP, Gross CP, Van Houten H, Thompson RH, Abouassaly R, Weight C, Boorjian SA, Leibovich BC, Shah ND. The impact of targeted therapy on management of metastatic renal cell carcinoma: trends in systemic therapy and cytoreductive nephrectomy utilization. Urology. 2015 Feb; 85 (2):442-50
     View PubMed
221. Psutka SP, Boorjian SA, Lohse CM, Stewart SB, Tollefson MK, Cheville JC, Leibovich BC, Thompson RH. The association between metformin use and oncologic outcomes among surgically treated diabetic patients with localized renal cell carcinoma. Urol Oncol. 2015 Feb; 33 (2):67.e15-23 Epub 2014 Aug 19
     View PubMed
222. Thompson RH, Atwell T, Atwell T, Schmit G, Lohse CM, Kurup AN, Weisbrod A, Psutka SP, Stewart SB, Callstrom MR, Cheville JC, Boorjian SA, Leibovich BC. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses. Eur Urol. 2015 Feb; 67 (2):252-9 Epub 2014 Aug 06
     View PubMed
223. Stewart SB, Thompson RH, Psutka SP, Cheville JC, Lohse CM, Boorjian SA, Leibovich BC. Evaluation of the National Comprehensive Cancer Network and American Urological Association renal cell carcinoma surveillance guidelines. J Clin Oncol. 2014 Dec 20; 32 (36):4059-65 Epub 2014 Nov 17
     View PubMed
224. Stewart SB, Cheville JC, Sebo TJ, Frank I, Boorjian SA, Thompson RH, Gettman MT, Tollefson MK, Umbriet EC, Psutka SP, Bergstralh EJ, Rangel L, Karnes RJ. Gleason grading after neoadjuvant hormonal therapy retains prognostic value for systemic progression following radical prostatectomy. Prostate Cancer Prostatic Dis. 2014 Dec; 17(4):332-7. Epub 2014 Aug 26.
     View PubMed
225. Abel EJ, Linder BJ, Bauman TM, Bauer RM, Thompson RH, Thapa P, Devon ON, Tarrell RF, Frank I, Jarrard DF, Downs TM, Boorjian SA. Perioperative blood transfusion and radical cystectomy: does timing of transfusion affect bladder cancer mortality? Eur Urol. 2014 Dec; 66 (6):1139-47 Epub 2014 Sept 04
     View PubMed
226. Viers BR, Sukov WR, Gettman MT, Rangel LJ, Bergstralh EJ, Frank I, Tollefson MK, Thompson RH, Boorjian SA, Karnes RJ. Primary Gleason grade 4 at the positive margin is associated with metastasis and death among patients with Gleason 7 prostate cancer undergoing radical prostatectomy. Eur Urol. 2014 Dec; 66: (6)1116-24.
     View PubMed
227. Psutka SP, Stewart SB, Boorjian SA, Lohse CM, Tollefson MK, Cheville JC, Leibovich BC, Thompson RH. Diabetes mellitus is independently associated with an increased risk of mortality in patients with clear cell renal cell carcinoma. J Urol. 2014 Dec; 192 (6):1620-7 Epub 2014 June 12
     View PubMed
228. Viers BR, Boorjian SA, Frank I, Tarrell RF, Thapa P, Karnes RJ, Thompson RH, Tollefson MK. Pretreatment neutrophil-to-lymphocyte ratio is associated with advanced pathologic tumor stage and increased cancer-specific mortality among patients with urothelial carcinoma of the bladder undergoing radical cystectomy. Eur Urol. 2014 Dec; 66 (6):1157-64 Epub 2014 Feb 26
     View PubMed
229. Kaushik D, Frank I, Eisenberg MS, Cheville JC, Tarrell R, Thapa P, Thompson RH, Boorjian SA. Gender-specific survival following radical cystectomy for pT4 bladder cancer. World J Urol. 2014 Dec; 32 (6):1433-9 Epub 2013 Dec 21
     View PubMed
230. Kaag M, Trost L, Thompson RH, Favaretto R, Elliott V, Shariat SF, Maschino A, Vertosick E, Raman JD, Dalbagni G. Preoperative predictors of renal function decline after radical nephroureterectomy for upper tract urothelial carcinoma. BJU Int. 2014 Nov; 114(5):674-9.
     View PubMed
231. Haddad AQ, Wood CG, Abel EJ, Krabbe LM, Darwish OM, Thompson RH, Heckman JE, Merril MM, Gayed BA, Sagalowsky AI, Boorjian SA, Margulis V, Leibovich BC. Oncologic outcomes following surgical resection of renal cell carcinoma with inferior vena caval thrombus extending above the hepatic veins: a contemporary multicenter cohort. J Urol. 2014 Oct; 192 (4):1050-6 Epub 2014 Apr 02
     View PubMed
232. Abel EJ, Thompson RH, Margulis V, Heckman JE, Merril MM, Darwish OM, Krabbe LM, Boorjian SA, Leibovich BC, Wood CG. Perioperative outcomes following surgical resection of renal cell carcinoma with inferior vena cava thrombus extending above the hepatic veins: a contemporary multicenter experience. Eur Urol. 2014 Sep; 66 (3):584-92 Epub 2013 Nov 07
     View PubMed
233. Schmit GD, Schenck LA, Thompson RH, Boorjian SA, Kurup AN, Weisbrod AJ, Kor DJ, Callstrom MR, Atwell TD, Carter RE. Predicting renal cryoablation complications: new risk score based on tumor size and location and patient history. Radiology. 2014 Sep; 272 (3):903-10 Epub 2014 May 07
     View PubMed
234. Linder BJ, Thompson RH, Leibovich BC, Cheville JC, Lohse CM, Gastineau DA, Boorjian SA. The impact of perioperative blood transfusion on survival after nephrectomy for non-metastatic renal cell carcinoma (RCC). BJU Int. 2014 Sep; 114 (3):368-74 Epub 2014 Jan 29
     View PubMed
235. Welch BT, Callstrom MR, Morris JM, Kurup AN, Schmit GD, Weisbrod AJ, Lohse CM, Kohli M, Costello BA, Olivier KR, Thompson RH, Boorjian SA, Atwell TD. Feasibility and oncologic control after percutaneous image guided ablation of metastatic renal cell carcinoma. J Urol. 2014 Aug; 192 (2):357-63 Epub 2014 Mar 12
     View PubMed
236. Kim SP, Gross CP, Nguyen PL, Smaldone MC, Shah ND, Karnes RJ, Thompson RH, Han LC, Yu JB, Trinh QD, Ziegenfuss JY, Sun M, Tilburt JC. Perceptions of Active Surveillance and Treatment Recommendations for Low-risk Prostate Cancer: Results from a National Survey of Radiation Oncologists and Urologists. Med Care. 2014 Jul; 52(7):579-85.
     View PubMed
237. Knoedler JJ, Karnes RJ, Thompson RH, Rangel LJ, Bergstralh EJ, Boorjian SA. The association of tumor volume with mortality following radical prostatectomy. Prostate Cancer Prostatic Dis. 2014 Jun; 17 (2):144-8 Epub 2014 Jan 28
     View PubMed
238. Kim SP, Gross CP, Nguyen PL, Smaldone MC, Thompson RH, Shah ND, Kutikov A, Han LC, Karnes RJ, Ziegenfuss JY, Tilburt JC. Specialty bias in treatment recommendations and quality of life among radiation oncologists and urologists for localized prostate cancer. Prostate Cancer Prostatic Dis. 2014 Jun; 17(2):163-9. Epub 2014 Feb 25.
     View PubMed
239. Kim SP, Karnes RJ, Nguyen PL, Ziegenfuss JY, Thompson RH, Han LC, Shah ND, Smaldone MC, Gross CP, Frank I, Weight CJ, Beebe TJ, Tilburt JC. A national survey of radiation oncologists and urologists on recommendations of prostate-specific antigen screening for prostate cancer. BJU Int. 2014 May; 113: (5b)E106-11.
     View PubMed
240. Greco F, Cadeddu JA, Gill IS, Kaouk JH, Remzi M, Thompson RH, van Leeuwen FW, van der Poel HG, Fornara P, Rassweiler J. Current perspectives in the use of molecular imaging to target surgical treatments for genitourinary cancers. Eur Urol. 2014 May; 65: (5)947-64.
     View PubMed
241. Thompson RH, Boorjian SA, Kim SP, Cheville JC, Thapa P, Tarrel R, Dronca R, Costello B, Frank I. Eligibility for neoadjuvant/adjuvant cisplatin-based chemotherapy among radical cystectomy patients. BJU Int. 2014 May; 113(5b):E17-21. Epub 2013 Sep 05.
     View PubMed
242. Schmit GD, Kurup AN, Weisbrod AJ, Thompson RH, Boorjian SA, Wass CT, Callstrom MR, Atwell TD. ABLATE: a renal ablation planning algorithm. AJR Am J Roentgenol. 2014 Apr; 202 (4):894-903
     View PubMed
243. Eisenberg MS, Thompson RH, Frank I, Kim SP, Cotter KJ, Tollefson MK, Kaushik D, Thapa P, Tarrell R, Boorjian SA. Long-term renal function outcomes after radical cystectomy. J Urol. 2014 Mar; 191 (3):619-25 Epub 2013 Sept 12
     View PubMed
244. Xylinas E, Robinson BD, Kluth LA, Volkmer BG, Hautmann R, Kufer R, Zerbib M, Kwon E, Thompson RH, Boorjian SA, Shariat SF. Association of T-cell co-regulatory protein expression with clinical outcomes following radical cystectomy for urothelial carcinoma of the bladder. Eur J Surg Oncol. 2014 Jan; 40 (1):121-7 Epub 2013 Sept 18
     View PubMed
245. Hubanks JM, Boorjian SA, Frank I, Gettman MT, Thompson RH, Rangel LJ, Bergstralh EJ, Karnes RJ. The presence of extracapsular extension is associated with an increased risk of death from prostate cancer after radical prostatectomy for patients with seminal vesicle invasion and negative lymph nodes. UROL. ONCOL. 2014; 32(1):26.e1-7.
     
246. Carrasco A, Thompson RH, Leibovich BC, Lohse CM, Cheville JC, Boorjian SA. The impact of histology on survival for patients with metastatic renal cell carcinoma undergoing cytoreductive nephrectomy. Indian J Urol. 2014 Jan; 30 (1):38-42
     View PubMed
247. Joseph RW, Parasramka M, Eckel-Passow JE, Serie D, Wu K, Jiang L, Kalari K, Thompson RH, Huu Ho T, Castle EP, Cheville J, Kwon ED, Thompson EA, Parker A. Inverse association between programmed death ligand 1 and genes in the VEGF pathway in primary clear cell renal cell carcinoma. Cancer Immunol Res. 2013 Dec; 1 (6):378-85 Epub 2013 Aug 29
     View PubMed
248. Eisenberg MS, Boorjian SA, Cheville JC, Thompson RH, Thapa P, Kaushik D, Frank I. The SPARC score: a multifactorial outcome prediction model for patients undergoing radical cystectomy for bladder cancer. J Urol. 2013 Dec; 190 (6):2005-10 Epub 2013 June 14
     View PubMed
249. Thiel DD, Jorns J, Lohse CM, Cheville JC, Thompson RH, Parker AS. Maximum tumor diameter is not an accurate predictor of renal cell carcinoma tumor volume. Scand J Urol. 2013 Dec; 47 (6):472-5 Epub 2013 July 24
     View PubMed
250. Kaushik D, Kim SP, Childs MA, Lohse CM, Costello BA, Cheville JC, Boorjian SA, Leibovich BC, Thompson RH. Overall survival and development of stage IV chronic kidney disease in patients undergoing partial and radical nephrectomy for benign renal tumors. Eur Urol. 2013 Oct; 64 (4):600-6 Epub 2012 Dec 25
     View PubMed
251. Wang JK, Tollefson MK, Kim SP, Boorjian SA, Leibovich BC, Lohse CM, Cheville JC, Thompson RH. Iatrogenic splenectomy during nephrectomy for renal tumors. Int J Urol. 2013 Sep; 20 (9):896-902 Epub 2013 Feb 04
     View PubMed
252. Schmit GD, Thompson RH, Boorjian SA, McDonald RJ, Kurup AN, Weisbrod AJ, Kor DJ, Callstrom MR, Atwell TD. Percutaneous renal cryoablation in obese and morbidly obese patients. Urology. 2013 Sep; 82(3):636-41. Epub 2013 Jul 26.
     View PubMed
253. Kim SP, Shah ND, Weight CJ, Thompson RH, Wang JK, Karnes RJ, Han LC, Ziegenfuss JY, Frank I, Tollefson MK, Boorjian SA. Population-based trends in urinary diversion among patients undergoing radical cystectomy for bladder cancer. BJU Int. 2013 Aug; 112 (4):478-84 Epub 2013 Mar 01
     View PubMed
254. Eisenberg MS, Cheville JC, Thompson RH, Kaushik D, Lohse CM, Boorjian SA, Costello BA, Leibovich BC. Association of microvascular and capillary-lymphatic invasion with outcome in patients with renal cell carcinoma. J Urol. 2013 Jul; 190 (1):37-43 Epub 2013 Jan 23
     View PubMed
255. Boorjian SA, Kim SP, Tollefson MK, Carrasco A, Cheville JC, Thompson RH, Thapa P, Frank I. Comparative performance of comorbidity indices for estimating perioperative and 5-year all cause mortality following radical cystectomy for bladder cancer. J Urol. 2013 Jul; 190 (1):55-60 Epub 2013 Jan 09
     View PubMed
256. Kim SP, Shah ND, Karnes RJ, Weight CJ, Shippee ND, Han LC, Boorjian SA, Smaldone MC, Frank I, Gettman MT, Tollefson MK, Thompson RH. Hospitalization costs for radical prostatectomy attributable to robotic surgery. Eur Urol. 2013 Jul; 64(1):11-6. Epub 2012 Aug 20.
     View PubMed
257. Kaushik D, Linder BJ, Thompson RH, Eisenberg MS, Lohse CM, Cheville JC, Leibovich BC, Boorjian SA. The impact of histology on clinicopathologic outcomes for patients with renal cell carcinoma and venous tumor thrombus: a matched cohort analysis. Urology. 2013 Jul; 82 (1):136-41 Epub 2013 May 01
     View PubMed
258. Kim SP, Karnes RJ, Nguyen PL, Ziegenfuss JY, Han LC, Thompson RH, Trinh QD, Sun M, Boorjian SA, Beebe TJ, Tilburt JC. Clinical implementation of quality of life instruments and prediction tools for localized prostate cancer: results from a national survey of radiation oncologists and urologists. J Urol. 2013 Jun; 189(6):2092-8. Epub 2012 Dec 03.
     View PubMed
259. Weight CJ, Kim SP, Jacobson DJ, McGree ME, Boorjian SA, Thompson RH, Leibovich BC, Karnes RJ, St Sauver J. The effect of benign lower urinary tract symptoms on subsequent prostate cancer testing and diagnosis. Eur Urol. 2013 Jun; 63(6):1021-7. Epub 2013 Jan 04.
     View PubMed
260. Zhang BY, Thompson RH, Lohse CM, Dronca RS, Cheville JC, Kwon ED, Leibovich BC. Carbonic anhydrase IX (CAIX) is not an independent predictor of outcome in patients with clear cell renal cell carcinoma (ccRCC) after long-term follow-up. BJU Int. 2013 Jun; 111 (7):1046-53 Epub 2013 Apr 02
     View PubMed
261. Linder BJ, Frank I, Cheville JC, Thompson RH, Thapa P, Tarrell RF, Boorjian SA. Outcomes following radical cystectomy for nested variant of urothelial carcinoma: a matched cohort analysis. J Urol. 2013 May; 189(5):1670-5. Epub 2012 Nov 06.
     View PubMed
262. Linder BJ, Frank I, Cheville JC, Tollefson MK, Thompson RH, Tarrell RF, Thapa P, Boorjian SA. The impact of perioperative blood transfusion on cancer recurrence and survival following radical cystectomy. Eur Urol. 2013 May; 63 (5):839-45 Epub 2013 Jan 11
     View PubMed
263. Weight CJ, Crispen PL, Breau RH, Kim SP, Lohse CM, Boorjian SA, Thompson RH, Leibovich BC. Practice-setting and surgeon characteristics heavily influence the decision to perform partial nephrectomy among American Urologic Association surgeons. BJU Int. 2013 May; 111 (5):731-8 Epub 2012 Apr 13
     View PubMed
264. Hegg RM, Schmit GD, Boorjian SA, McDonald RJ, Kurup AN, Weisbrod AJ, Callstrom MR, Atwell TD, Thompson RH. Percutaneous renal cryoablation after partial nephrectomy: technical feasibility, complications and outcomes. J Urol. 2013 Apr; 189(4):1243-8. Epub 2012 Oct 30.
     View PubMed
265. Kim SP, Leibovich BC, Shah ND, Weight CJ, Borah BJ, Han LC, Boorjian SA, Thompson RH. The relationship of postoperative complications with in-hospital outcomes and costs after renal surgery for kidney cancer. BJU Int. 2013 Apr; 111(4):580-8. Epub 2012 May 07.
     View PubMed
266. Delahunt B, McKenney JK, Lohse CM, Leibovich BC, Thompson RH, Boorjian SA, Cheville JC. A novel grading system for clear cell renal cell carcinoma incorporating tumor necrosis. Am J Surg Pathol. 2013 Mar; 37 (3):311-22
     View PubMed
267. Kim SP, Thompson RH. Kidney function after partial nephrectomy: current thinking. Curr Opin Urol. 2013 Mar; 23(2):105-11.
     View PubMed
268. Atwell TD, Schmit GD, Boorjian SA, Mandrekar J, Mandrekar J, Kurup AN, Weisbrod AJ, Chow GK, Leibovich BC, Callstrom MR, Patterson DE, Lohse CM, Thompson RH. Percutaneous ablation of renal masses measuring 3.0 cm and smaller: comparative local control and complications after radiofrequency ablation and cryoablation. AJR Am J Roentgenol. 2013 Feb; 200 (2):461-6
     View PubMed
269. Kim SP, Boorjian SA, Shah ND, Weight CJ, Tilburt JC, Han LC, Thompson RH, Trinh QD, Sun M, Moriarty JP, Karnes RJ. Disparities in access to hospitals with robotic surgery for patients with prostate cancer undergoing radical prostatectomy. J Urol. 2013 Feb; 189 (2):514-20 Epub 2012 Dec 17
     View PubMed
270. Junker K, Ficarra V, Kwon ED, Leibovich BC, Thompson RH, Oosterwijk E. Potential role of genetic markers in the management of kidney cancer. Eur Urol. 2013 Feb; 63(2):333-40. Epub 2012 Sep 24.
     View PubMed
271. Sudarshan S, Karam JA, Brugarolas J, Thompson RH, Uzzo R, Rini B, Margulis V, Patard JJ, Escudier B, Linehan WM. Metabolism of kidney cancer: from the lab to clinical practice. Eur Urol. 2013 Feb; 63(2):244-51. Epub 2012 Sep 28.
     View PubMed
272. Schmit GD, Thompson RH, Kurup AN, Weisbrod AJ, Boorjian SA, Carter RE, Geske JR, Callstrom MR, Atwell TD. Usefulness of R.E.N.A.L. nephrometry scoring system for predicting outcomes and complications of percutaneous ablation of 751 renal tumors. J Urol. 2013 Jan; 189 (1):30-5 Epub 2012 Nov 16
     View PubMed
273. Schmit GD, Thompson RH, Kurup AN, Weisbrod AJ, Carter RE, Callstrom MR, Atwell TD. Percutaneous cryoablation of solitary sporadic renal cell carcinomas. BJU Int. 2012 Dec; 110(11 Pt B):E526-31. Epub 2012 May 15.
     View PubMed
274. Boorjian SA, Tollefson MK, Thompson RH, Rangel LJ, Bergstralh EJ, Karnes RJ. Natural history of biochemical recurrence after radical prostatectomy with adjuvant radiation therapy. J Urol. 2012 Nov; 188(5):1761-6. Epub 2012 Sep 19.
     View PubMed
275. Zarei S, Frank I, Boorjian SA, Thompson RH, Kim S, Weight C, Tarrell R, Thapa P, Cheville JC. Prognostic significance of measured depth of invasion of urothelial carcinoma of the bladder compared to the 2010 American Joint Committee on Cancer pT2 and pT3 classifications. J Urol. 2012 Nov; 188(5):1706-11. Epub 2012 Sep 19.
     View PubMed
276. Kurup AN, Thompson RH, Leibovich BC, Harmsen WS, Sebo TJ, Callstrom MR, Kawashima A, Atwell TD. Renal oncocytoma growth rates before intervention. BJU Int. 2012 Nov; 110 (10):1444-8 Epub 2012 Apr 23
     View PubMed
277. Sukov WR, Hodge JC, Lohse CM, Akre MK, Leibovich BC, Thompson RH, Cheville JC. ALK alterations in adult renal cell carcinoma: frequency, clinicopathologic features and outcome in a large series of consecutively treated patients. Mod Pathol. 2012 Nov; 25 (11):1516-25 Epub 2012 June 29
     View PubMed
278. Kim SP, Crispen PL, Thompson RH, Weight CJ, Boorjian SA, Costello BA, Lohse CM, Leibovich BC. Assessment of the pathologic inclusion criteria from contemporary adjuvant clinical trials for predicting disease progression after nephrectomy for renal cell carcinoma. Cancer. 2012 Sep 15; 118 (18):4412-20 Epub 2012 Jan 03
     View PubMed
279. Kim SP, Frank I, Cheville JC, Thompson RH, Weight CJ, Thapa P, Boorjian SA. The impact of squamous and glandular differentiation on survival after radical cystectomy for urothelial carcinoma. J Urol. 2012 Aug; 188 (2):405-9 Epub 2012 June 14
     View PubMed
280. Kim SP, Thompson RH, Boorjian SA, Weight CJ, Han LC, Murad MH, Shippee ND, Erwin PJ, Costello BA, Chow GK, Leibovich BC. Comparative effectiveness for survival and renal function of partial and radical nephrectomy for localized renal tumors: a systematic review and meta-analysis. J Urol. 2012 Jul; 188 (1):51-7 Epub 2012 May 14
     View PubMed
281. Cheville JC, Lohse CM, Sukov WR, Thompson RH, Leibovich BC. Chromophobe renal cell carcinoma: the impact of tumor grade on outcome. Am J Surg Pathol. 2012 Jun; 36 (6):851-6
     View PubMed
282. Kim SP, Thompson RH. Approach to the small renal mass: to treat or not to treat. Urol Clin North Am. 2012 May; 39 (2):171-9, vi Epub 2012 Feb 21
     View PubMed
283. Sukov WR, Hodge JC, Lohse CM, Leibovich BC, Thompson RH, Pearce KE, Wiktor AE, Cheville JC. TFE3 rearrangements in adult renal cell carcinoma: clinical and pathologic features with outcome in a large series of consecutively treated patients. Am J Surg Pathol. 2012 May; 36 (5):663-70
     View PubMed
284. Wang JK, Tollefson MK, Krambeck AE, Trost LW, Thompson RH. High rate of pathologic upgrading at nephroureterectomy for upper tract urothelial carcinoma. Urology. 2012 Mar; 79(3):615-9.
     View PubMed
285. Thompson RH, Carver BS, Bosl GJ, Bajorin D, Motzer R, Feldman D, Reuter VE, Sheinfeld J. Body mass index is associated with higher lymph node counts during retroperitoneal lymph node dissection. Urology. 2012 Feb; 79(2):361-4. Epub 2011 Dec 14.
     View PubMed
286. Thompson RH, Lane BR, Lohse CM, Leibovich BC, Fergany A, Frank I, Gill IS, Blute ML, Campbell SC. Renal function after partial nephrectomy: effect of warm ischemia relative to quantity and quality of preserved kidney. Urology. 2012 Feb; 79 (2):356-60
     View PubMed
287. Atwell TD, Carter RE, Schmit GD, Carr CM, Boorjian SA, Curry TB, Thompson RH, Kurup AN, Weisbrod AJ, Chow GK, Leibovich BC, Callstrom MR, Patterson DE. Complications following 573 percutaneous renal radiofrequency and cryoablation procedures. J Vasc Interv Radiol. 2012 Jan; 23(1):48-54. Epub 2011 Oct 28.
     View PubMed
288. Sukov WR, Lohse CM, Leibovich BC, Thompson RH, Cheville JC. Clinical and pathological features associated with prognosis in patients with papillary renal cell carcinoma. J Urol. 2012 Jan; 187 (1):54-9 Epub 2011 Nov 16
     View PubMed
289. Umbreit EC, Shimko MS, Childs MA, Lohse CM, Cheville JC, Leibovich BC, Blute ML, Thompson RH. Metastatic potential of a renal mass according to original tumour size at presentation. BJU Int. 2012 Jan; 109 (2):190-4; discussion 194 Epub 2011 May 09
     View PubMed
290. Kim SP, Weight CJ, Leibovich BC, Thompson RH, Costello BA, Cheville JC, Lohse CM, Boorjian SA. Outcomes and clinicopathologic variables associated with late recurrence after nephrectomy for localized renal cell carcinoma. Urology. 2011 Nov; 78 (5):1101-6 Epub 2011 Sept 08
     View PubMed
291. Kim SP, Shah ND, Weight CJ, Thompson RH, Moriarty JP, Shippee ND, Costello BA, Boorjian SA, Leibovich BC. Contemporary trends in nephrectomy for renal cell carcinoma in the United States: results from a population based cohort. J Urol. 2011 Nov; 186 (5):1779-85 Epub 2011 Sept 25
     View PubMed
292. Mitchell CR, Atwell TD, Weisbrod AJ, Lohse CM, Boorjian SA, Leibovich BC, Thompson RH. Renal function outcomes in patients treated with partial nephrectomy versus percutaneous ablation for renal tumors in a solitary kidney. J Urol. 2011 Nov; 186 (5):1786-90 Epub 2011 Sept 25
     View PubMed
293. Kaag MG, Milowsky MI, Dalbagni G, Thompson RH, Katz D, Reuter VE, Herr HW, Bajorin D, Bochner BH. Regional lymph node status in patients with bladder cancer found to be pathological stage T0 at radical cystectomy following systemic chemotherapy. BJU Int. 2011 Oct; 108(8 Pt 2):E272-7. Epub 2011 Feb 14.
     View PubMed
294. Weight CJ, Atwell TD, Fazzio RT, Kim SP, Kenny M, Lohse CM, Boorjian SA, Leibovich BC, Thompson RH. A multidisciplinary evaluation of inter-reviewer agreement of the nephrometry score and the prediction of long-term outcomes. J Urol. 2011 Oct; 186 (4):1223-8 Epub 2011 Aug 17
     View PubMed
295. Childs MA, Breau RH, Umbreit EC, Lohse CM, Cheville JC, Thompson RH, Blute ML, Leibovich BC. Metachronous renal tumours after surgical management of oncocytoma. BJU Int. 2011 Sep; 108 (6):816-9 Epub 2010 Dec 16
     View PubMed
296. Weight CJ, Kim SP, Lohse CM, Cheville JC, Thompson RH, Boorjian SA, Leibovich BC. Routine adrenalectomy in patients with locally advanced renal cell cancer does not offer oncologic benefit and places a significant portion of patients at risk for an asynchronous metastasis in a solitary adrenal gland. Eur Urol. 2011 Sep; 60 (3):458-64 Epub 2011 Apr 16
     View PubMed
297. Boorjian SA, Thompson RH, Tollefson MK, Rangel LJ, Bergstralh EJ, Blute ML, Karnes RJ. Long-term risk of clinical progression after biochemical recurrence following radical prostatectomy: the impact of time from surgery to recurrence. Eur Urol. 2011 Jun; 59 (6):893-9 Epub 2011 Feb 22
     View PubMed
298. Kaag MG, Toyen C, Russo P, Cronin A, Thompson RH, Schiff J, Bernstein M, Bains M. Radical nephrectomy with vena caval thrombectomy: a contemporary experience. BJU Int. 2011 May; 107(9):1386-93. Epub 2010 Sep 30.
     View PubMed
299. Frigola X, Inman BA, Lohse CM, Krco CJ, Cheville JC, Thompson RH, Leibovich B, Blute ML, Dong H, Kwon ED. Identification of a soluble form of B7-H1 that retains immunosuppressive activity and is associated with aggressive renal cell carcinoma. Clin Cancer Res. 2011 Apr 1; 17 (7):1915-23 Epub 2011 Feb 25
     View PubMed
300. Thompson RH, Carver BS, Bosl GJ, Bajorin D, Motzer R, Feldman DR, Reuter VE, Sheinfeld J. Contemporary lymph node counts during primary retroperitoneal lymph node dissection. Urology. 2011 Feb; 77(2):368-72. Epub 2010 Dec 15.
     View PubMed
301. Lane BR, Russo P, Uzzo RG, Hernandez AV, Boorjian SA, Thompson RH, Fergany AF, Love TE, Campbell SC. Comparison of cold and warm ischemia during partial nephrectomy in 660 solitary kidneys reveals predominant role of nonmodifiable factors in determining ultimate renal function. J Urol. 2011 Feb; 185(2):421-7. Epub 2010 Dec 17.
     View PubMed
302. Thompson RH, Carver BS, Bosl GJ, Bajorin D, Motzer R, Feldman D, Reuter VE, Sheinfeld J. Evaluation of lymph node counts in primary retroperitoneal lymph node dissection. Cancer. 2010 Nov 15; 116(22):5243-50.
     View PubMed
303. Kundu SD, Thompson RH, Kallingal GJ, Cambareri G, Russo P. Urinary fistulae after partial nephrectomy. BJU Int. 2010 Oct; 106(7):1042-4. Epub 2010 Mar 04.
     View PubMed
304. Thompson RH, Lane BR, Lohse CM, Leibovich BC, Fergany A, Frank I, Gill IS, Campbell SC, Blute ML. Comparison of warm ischemia versus no ischemia during partial nephrectomy on a solitary kidney. Eur Urol. 2010 Sep; 58 (3):331-6 Epub 2010 June 09
     View PubMed
305. Thompson RH, Lane BR, Lohse CM, Leibovich BC, Fergany A, Frank I, Gill IS, Blute ML, Campbell SC. Every minute counts when the renal hilum is clamped during partial nephrectomy. Eur Urol. 2010 Sep; 58 (3):340-5 Epub 2010 June 09
     View PubMed
306. Leibovich BC, Lohse CM, Crispen PL, Boorjian SA, Thompson RH, Blute ML, Cheville JC. Histological subtype is an independent predictor of outcome for patients with renal cell carcinoma. J Urol. 2010 Apr; 183 (4):1309-15 Epub 2010 Feb 19
     View PubMed
307. Lowrance WT, Yee DS, Maschino AC, Cronin AM, Bernstein M, Thompson RH, Russo P. Developments in the surgical management of sporadic synchronous bilateral renal tumours. BJU Int. 2010 Apr; 105(8):1093-7. Epub 2009 Sep 14.
     View PubMed
308. Lowrance WT, Thompson RH, Yee DS, Kaag M, Donat SM, Russo P. Obesity is associated with a higher risk of clear-cell renal cell carcinoma than with other histologies. BJU Int. 2010 Jan; 105(1):16-20. Epub 2009 Jul 06.
     View PubMed
309. Thompson RH, Siddiqui S, Lohse CM, Leibovich BC, Russo P, Blute ML. Partial versus radical nephrectomy for 4 to 7 cm renal cortical tumors. J Urol. 2009 Dec; 182 (6):2601-6 Epub 2009 Oct 17
     View PubMed
310. Teloken PE, Thompson RH, Tickoo SK, Cronin A, Savage C, Reuter VE, Russo P. Prognostic impact of histological subtype on surgically treated localized renal cell carcinoma. J Urol. 2009 Nov; 182(5):2132-6. Epub 2009 Sep 16.
     View PubMed
311. Thompson RH, Hill JR, Babayev Y, Cronin A, Kaag M, Kundu S, Bernstein M, Coleman J, Dalbagni G, Touijer K, Russo P. Metastatic renal cell carcinoma risk according to tumor size. J Urol. 2009 Jul; 182(1):41-5. Epub 2009 May 17.
     View PubMed
312. Thompson RH, Kurta JM, Kaag M, Tickoo SK, Kundu S, Katz D, Nogueira L, Reuter VE, Russo P. Tumor size is associated with malignant potential in renal cell carcinoma cases. J Urol. 2009 May; 181(5):2033-6. Epub 2009 Mar 14.
     View PubMed
313. Thompson RH, Kaag M, Vickers A, Kundu S, Bernstein M, Lowrance W, Galvin D, Dalbagni G, Touijer K, Russo P. Contemporary use of partial nephrectomy at a tertiary care center in the United States. J Urol. 2009 Mar; 181(3):993-7. Epub 2009 Jan 16.
     View PubMed
314. Thompson RH, Eastham JA, Scardino PT, Sheinfeld J. Critical elements in fellowship training. Urol Oncol. 2009 Mar-Apr; 27(2):199-204.
     View PubMed
315. Thompson RH, Kwon ED, Allison JP. Inhibitors of B7-CD28 costimulation in urologic malignancies. Immunotherapy. 2009 Jan; 1(1):129-39.
     View PubMed
316. Kurta JM, Thompson RH, Kundu S, Kaag M, Manion MT, Herr HW, Russo P. Contemporary imaging of patients with a renal mass: does size on computed tomography equal pathological size? BJU Int. 2009 Jan; 103(1):24-7. Epub 2008 Aug 14.
     View PubMed
317. Thompson RH, Krambeck AE, Lohse CM, Elliott DS, Patterson DE, Blute ML. Elective endoscopic management of transitional cell carcinoma first diagnosed in the upper urinary tract. BJU Int. 2008 Nov; 102 (9):1107-10 Epub 2008 June 03
     View PubMed
318. Pettus JA, Jang TL, Thompson RH, Yossepowitch O, Kagiwada M, Russo P. Effect of baseline glomerular filtration rate on survival in patients undergoing partial or radical nephrectomy for renal cortical tumors. Mayo Clin Proc. 2008 Oct; 83(10):1101-6.
     View PubMed
319. Thompson RH, Ordonez MA, Iasonos A, Secin FP, Guillonneau B, Russo P, Touijer K. Renal cell carcinoma in young and old patients--is there a difference? J Urol. 2008 Oct; 180(4):1262-6; discussion 1266. Epub 2008 Aug 15.
     View PubMed
320. Crispen PL, Sheinin Y, Roth TJ, Lohse CM, Kuntz SM, Frigola X, Thompson RH, Boorjian SA, Dong H, Leibovich BC, Blute ML, Kwon ED. Tumor cell and tumor vasculature expression of B7-H3 predict survival in clear cell renal cell carcinoma. Clin Cancer Res. 2008 Aug 15; 14 (16):5150-7 Epub 2008 Aug 11
     View PubMed
321. Thompson RH, Zang X, Lohse CM, Leibovich BC, Slovin SF, Reuter VE, Cheville JC, Blute ML, Russo P, Kwon ED, Allison JP. Serum-soluble B7x is elevated in renal cell carcinoma patients and is associated with advanced stage. Cancer Res. 2008 Aug 1; 68 (15):6054-8
     View PubMed
322. Raj GV, Thompson RH, Leibovich BC, Blute ML, Russo P, Kattan MW. Preoperative nomogram predicting 12-year probability of metastatic renal cancer. J Urol. 2008 Jun; 179(6):2146-51; discussion 2151. Epub 2008 Apr 18.
     View PubMed
323. Yossepowitch O, Thompson RH, Leibovich BC, Eggener SE, Pettus JA, Kwon ED, Herr HW, Blute ML, Russo P. Positive surgical margins at partial nephrectomy: predictors and oncological outcomes. J Urol. 2008 Jun; 179(6):2158-63.
     View PubMed
324. Thompson RH, Krambeck AE, Lohse CM, Elliott DS, Patterson DE, Blute ML. Endoscopic management of upper tract transitional cell carcinoma in patients with normal contralateral kidneys. Urology. 2008 Apr; 71 (4):713-7 Epub 2008 Feb 11
     View PubMed
325. Thompson RH, Leibovich BC, Karnes RJ, Bergstralh EJ, Blute ML. Radical retropubic prostatectomy in immunosuppressed transplant recipients. J Urol. 2008 Apr; 179 (4):1349-52; discussion 1352-3 Epub 2008 Mar 04
     View PubMed
326. Thompson RH, Boorjian SA, Lohse CM, Leibovich BC, Kwon ED, Cheville JC, Blute ML. Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy. J Urol. 2008 Feb; 179 (2):468-71; discussion 472-3
     View PubMed
327. Zang X, Thompson RH, Al-Ahmadie HA, Serio AM, Reuter VE, Eastham JA, Scardino PT, Sharma P, Allison JP. B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcome. Proc Natl Acad Sci U S A. 2007 Dec 4; 104(49):19458-63. Epub 2007 Nov 27.
     View PubMed
328. Webster WS, Thompson RH, Cheville JC, Lohse CM, Blute ML, Leibovich BC. Surgical resection provides excellent outcomes for patients with cystic clear cell renal cell carcinoma. Urology. 2007 Nov; 70 (5):900-4; discussion 904
     View PubMed
329. Leibovich BC, Sheinin Y, Lohse CM, Thompson RH, Cheville JC, Zavada J, Kwon ED. Carbonic anhydrase IX is not an independent predictor of outcome for patients with clear cell renal cell carcinoma. J Clin Oncol. 2007 Oct 20; 25 (30):4757-64
     View PubMed
330. Krambeck AE, Thompson RH, Lohse CM, Patterson DE, Elliott DS, Blute ML. Imperative indications for conservative management of upper tract transitional cell carcinoma. J Urol. 2007 Sep; 178 (3 Pt 1):792-6; discussion 796-7 Epub 2007 July 16
     View PubMed
331. Boorjian SA, Thompson RH, Siddiqui S, Bagniewski S, Bergstralh EJ, Karnes RJ, Frank I, Blute ML. Long-term outcome after radical prostatectomy for patients with lymph node positive prostate cancer in the prostate specific antigen era. J Urol. 2007 Sep; 178(3 Pt 1):864-70; discussion 870-1. Epub 2007 Jul 16.
     View PubMed
332. Webster WS, Thompson RH, Harris KJ, Frigola X, Kuntz S, Inman BA, Dong H. Targeting molecular and cellular inhibitory mechanisms for improvement of antitumor memory responses reactivated by tumor cell vaccine. J Immunol. 2007 Sep 1; 179 (5):2860-9
     View PubMed
333. Tollefson MK, Thompson RH, Sheinin Y, Lohse CM, Cheville JC, Leibovich BC, Kwon ED. Ki-67 and coagulative tumor necrosis are independent predictors of poor outcome for patients with clear cell renal cell carcinoma and not surrogates for each other. Cancer. 2007 Aug 15; 110 (4):783-90
     View PubMed
334. Thompson RH, Blute ML, Slezak JM, Bergstralh EJ, Leibovich BC. Is the GPSM scoring algorithm for patients with prostate cancer valid in the contemporary era? J Urol. 2007 Aug; 178(2):459-63; discussion 463. Epub 2007 Jun 11.
     View PubMed
335. Thompson RH, Blute ML, Krambeck AE, Lohse CM, Magera JS, Leibovich BC, Kwon ED, Frank I, Cheville JC. Patients with pT1 renal cell carcinoma who die from disease after nephrectomy may have unrecognized renal sinus fat invasion. Am J Surg Pathol. 2007 Jul; 31 (7):1089-93
     View PubMed
336. Krambeck AE, Thompson RH, Lohse CM, Patterson DE, Segura JW, Zincke H, Elliott DS, Blute ML. Endoscopic management of upper tract urothelial carcinoma in patients with a history of bladder urothelial carcinoma. J Urol. 2007 May; 177 (5):1721-6
     View PubMed
337. Thompson RH, Dong H, Lohse CM, Leibovich BC, Blute ML, Cheville JC, Kwon ED. PD-1 is expressed by tumor-infiltrating immune cells and is associated with poor outcome for patients with renal cell carcinoma. Clin Cancer Res. 2007 Mar 15; 13 (6):1757-61
     View PubMed
338. Krambeck AE, Dong H, Thompson RH, Kuntz SM, Lohse CM, Leibovich BC, Blute ML, Sebo TJ, Cheville JC, Parker AS, Kwon ED. Survivin and b7-h1 are collaborative predictors of survival and represent potential therapeutic targets for patients with renal cell carcinoma. Clin Cancer Res. 2007 Mar 15; 13 (6):1749-56
     View PubMed
339. Thompson RH, Frank I, Lohse CM, Saad IR, Fergany A, Zincke H, Leibovich BC, Blute ML, Novick AC. The impact of ischemia time during open nephron sparing surgery on solitary kidneys: a multi-institutional study. J Urol. 2007 Feb; 177 (2):471-6
     View PubMed
340. Thompson RH, Leibovich BC, Lohse CM, Cheville JC, Zincke H, Blute ML, Frank I. Dynamic outcome prediction in patients with clear cell renal cell carcinoma treated with radical nephrectomy: the D-SSIGN score. J Urol. 2007 Feb; 177 (2):477-80
     View PubMed
341. Thompson RH, Dong H, Kwon ED. Implications of B7-H1 expression in clear cell carcinoma of the kidney for prognostication and therapy. Clin Cancer Res. 2007 Jan 15; 13 (2 Pt 2):709s-715s
     View PubMed
342. Thompson RH, Kwon ED. Significance of B7-H1 overexpression in kidney cancer. Clin Genitourin Cancer. 2006 Dec; 5 (3):206-11
     View PubMed
343. Thompson RH, Slezak JM, Webster WS, Lieber MM. Radical prostatectomy for octogenarians: how old is too old? Urology. 2006 Nov; 68(5):1042-5. Epub 2006 Nov 07.
     View PubMed
344. Thompson RH. Radical nephrectomy: too radical for small renal masses? Lancet. 2006 Sep 2; 368(9538):823-4.
     View PubMed
345. Thompson RH, Leibovich BC, Cheville JC, Webster WS, Lohse CM, Kwon ED, Zincke H, Blute ML. Second primary malignancies associated with renal cell carcinoma histological subtypes. J Urol. 2006 Sep; 176 (3):900-3; discussion 903-4
     View PubMed
346. Thompson RH, Allison JP, Kwon ED. Anti-cytotoxic T lymphocyte antigen-4 (CTLA-4) immunotherapy for the treatment of prostate cancer. Urol Oncol. 2006 Sep-Oct; 24 (5):442-7
     View PubMed
347. Krambeck AE, Thompson RH, Dong H, Lohse CM, Park ES, Kuntz SM, Leibovich BC, Blute ML, Cheville JC, Kwon ED. B7-H4 expression in renal cell carcinoma and tumor vasculature: associations with cancer progression and survival. Proc Natl Acad Sci U S A. 2006 Jul 5; 103 (27):10391-10396 Epub 2006 June 23
     View PubMed
348. Webster WS, Lohse CM, Thompson RH, Dong H, Frigola X, Dicks DL, Sengupta S, Frank I, Leibovich BC, Blute ML, Cheville JC, Kwon ED. Mononuclear cell infiltration in clear-cell renal cell carcinoma independently predicts patient survival. Cancer. 2006 Jul 1; 107 (1):46-53
     View PubMed
349. Thompson RH, Kuntz SM, Leibovich BC, Dong H, Lohse CM, Webster WS, Sengupta S, Frank I, Parker AS, Zincke H, Blute ML, Sebo TJ, Cheville JC, Kwon ED. Tumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow-up. Cancer Res. 2006 Apr 1; 66 (7):3381-5
     View PubMed
350. Sengupta S, Lohse CM, Cheville JC, Leibovich BC, Thompson RH, Webster WS, Frank I, Zincke H, Blute ML, Kwon ED. The preoperative erythrocyte sedimentation rate is an independent prognostic factor in renal cell carcinoma. Cancer. 2006 Jan 15; 106 (2):304-12
     View PubMed
351. Thompson RH, Dicks D, Kramer SA. Clinical manifestations and functional outcomes in children with eosinophilic cystitis. J Urol. 2005 Dec; 174(6):2347-9.
     View PubMed
352. Thompson RH, Gillett MD, Cheville JC, Lohse CM, Dong H, Webster WS, Chen L, Zincke H, Blute ML, Leibovich BC, Kwon ED. Costimulatory molecule B7-H1 in primary and metastatic clear cell renal cell carcinoma. Cancer. 2005 Nov 15; 104 (10):2084-91
     View PubMed
353. Thompson RH, Webster WS, Cheville JC, Lohse CM, Dong H, Leibovich BC, Kuntz SM, Sengupta S, Kwon ED, Blute ML. B7-H1 glycoprotein blockade: a novel strategy to enhance immunotherapy in patients with renal cell carcinoma. Urology. 2005 Nov; 66 (5 Suppl):10-4
     View PubMed
354. Thompson RH, Leibovich BC, Cheville JC, Webster WS, Lohse CM, Kwon ED, Frank I, Zincke H, Blute ML. Is renal sinus fat invasion the same as perinephric fat invasion for pT3a renal cell carcinoma? J Urol. 2005 Oct; 174 (4 Pt 1):1218-21
     View PubMed
355. Thompson RH, Leibovich BC, Lohse CM, Zincke H, Blute ML. Complications of contemporary open nephron sparing surgery: a single institution experience. J Urol. 2005 Sep; 174 (3):855-8
     View PubMed
356. Sengupta S, Lohse CM, Leibovich BC, Frank I, Thompson RH, Webster WS, Zincke H, Blute ML, Cheville JC, Kwon ED. Histologic coagulative tumor necrosis as a prognostic indicator of renal cell carcinoma aggressiveness. Cancer. 2005 Aug 1; 104 (3):511-20
     View PubMed
357. Thompson RH, Cheville JC, Lohse CM, Webster WS, Zincke H, Kwon ED, Frank I, Blute ML, Leibovich BC. Reclassification of patients with pT3 and pT4 renal cell carcinoma improves prognostic accuracy. Cancer. 2005 Jul 1; 104 (1):53-60
     View PubMed
358. Thompson RH, Leibovich BC, Cheville JC, Lohse CM, Frank I, Kwon ED, Zincke H, Blute ML. Should direct ipsilateral adrenal invasion from renal cell carcinoma be classified as pT3a? J Urol. 2005 Mar; 173 (3):918-21
     View PubMed
359. Leibovich BC, Cheville JC, Lohse CM, Zincke H, Kwon ED, Frank I, Thompson RH, Blute ML. Cancer specific survival for patients with pT3 renal cell carcinoma-can the 2002 primary tumor classification be improved? J Urol. 2005 Mar; 173 (3):716-9
     View PubMed
360. Thompson RH, Gillett MD, Cheville JC, Lohse CM, Dong H, Webster WS, Krejci KG, Lobo JR, Sengupta S, Chen L, Zincke H, Blute ML, Leibovich BC, Kwon ED. Aberrant expression of costimulatory B7-H1 in clear cell renal cell carcinoma. The American Journal of Urology Review. 2005; 3(5):244-9.
     
361. Thompson RH, Gillett MD, Cheville JC, Lohse CM, Dong H, Webster WS, Krejci KG, Lobo JR, Sengupta S, Chen L, Zincke H, Blute ML, Strome SE, Leibovich BC, Kwon ED. Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target. Proc Natl Acad Sci U S A. 2004 Dec 7; 101 (49):17174-9 Epub 2004 Nov 29
     View PubMed
362. Kwon E, Thompson RH, Gillett M, Cheville J, Lohse C, Dong H, Webster WS, Krejci K, Lobo J, Sengupta S, Leiping C, Zincke H, Blute ML, Strome S, Leibovich BC. Immune cell marker expressed in kidney cancer and predicts aggressiveness. Cancer Biology and Therapy. 2004 Dec; 3(12):1199.
     
363. Thompson RH, Hartman RP, Lowe VJ, Kawashima A, Leibovich BC. Applications of positron emission tomography imaging, intraoperative ultrasonography, magnetic resonance imaging, and angiography in the evaluation of renal masses. Curr Urol Rep. 2004 Feb; 5 (1):30-4
     View PubMed
364. Thompson RH, Chen JJ, Pugach J, Naseer S, Steinhardt GF. Cessation of prophylactic antibiotics for managing persistent vesicoureteral reflux. J Urol. 2001 Oct; 166(4):1465-9.
     View PubMed